{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:12:53Z","timestamp":1790835173709,"version":"4.1.0"},"reference-count":595,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CM1103"],"award-info":[{"award-number":["CM1103"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008980","name":"Soci\u00e9t\u00e9 Fran\u00e7aise de Radiologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008980","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neurobiology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.pneurobio.2016.07.002","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T13:07:35Z","timestamp":1467637655000},"page":"57-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":125,"special_numbering":"C","title":["Expanding the repertoire of L-DOPA\u2019s actions: A comprehensive review of its functional neurochemistry"],"prefix":"10.1016","volume":"151","author":[{"given":"Philippe","family":"De Deurwaerd\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Di Giovanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Millan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pneurobio.2016.07.002_bib0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0006-8993(90)91318-B","article-title":"Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats","volume":"525","author":"Abercrombie","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0304-3940(91)90690-U","article-title":"L-dopa stimulates the release of [3H]gamma-aminobutyric acid in the basal ganglia of 6-hydroxydopamine lesioned rats","volume":"121","author":"Aceves","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0015","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1471-4159.1992.tb08907.x","article-title":"Extracellular concentrations of dopamine and metabolites in the rat caudate after oral administration of a novel catechol-O-methyltransferase inhibitor Ro 40\u20137592","volume":"59","author":"Acquas","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0020","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/j.1471-4159.1993.tb13390.x","article-title":"In vivo brain dialysis study of the somatodendritic release of serotonin in the Raphe nuclei of the rat: effects of 8-hydroxy-2-(di-n-propylamino)tetralin","volume":"60","author":"Adell","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0025","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","article-title":"Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature","volume":"16","author":"Ahlskog","year":"2001","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0030","doi-asserted-by":"crossref","first-page":"28ra28","DOI":"10.1126\/scitranslmed.3000664","article-title":"Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease","volume":"2","author":"Ahmed","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neures.2010.03.008","article-title":"Binding of dopamine and 3-methoxytyramine as l-DOPA metabolites to human alpha(2)-adrenergic and dopaminergic receptors","volume":"67","author":"Alachkar","year":"2010","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neures.2010.06.003","article-title":"Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites","volume":"68","author":"Alachkar","year":"2010","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0045","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.neulet.2012.08.054","article-title":"Local administration of L-DOPA in the chicken ventromedial hypothalamus increases dopamine release in a dose-dependent manner","volume":"529","author":"Alam","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0050","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0055","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1523\/JNEUROSCI.0837-12.2012","article-title":"Galpha(olf) mutation allows parsing the role of cAMP-dependent and extracellular signal-regulated kinase-dependent signaling in L-3,4-dihydroxyphenylalanine-induced dyskinesia","volume":"32","author":"Alcacer","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0060","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuropharm.2010.10.018","article-title":"Differential induction of adenylyl cyclase supersensitivity by antiparkinson drugs acting as agonists at dopamine D1\/D2\/D3 receptors vs D2\/D3 receptors only: parallel observations from co-transfected human and native cerebral receptors","volume":"60","author":"Aloisi","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0065","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1460-9568.1995.tb01085.x","article-title":"Complex deficits on reaction time performance following bilateral intrastriatal 6-OHDA infusion in the rat","volume":"7","author":"Amalric","year":"1995","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0070","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1523\/JNEUROSCI.5196-09.2010","article-title":"VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety","volume":"30","author":"Amilhon","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0075","first-page":"317","article-title":"Effect of L-DOPA and analogues on central dopamine and noradrenaline mechanisms","volume":"5","author":"Anden","year":"1974","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00508076","article-title":"Mode of action of L-DOPA on central noradrenaline mechanisms","volume":"273","author":"Anden","year":"1972","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3940(95)11817-G","article-title":"L-DOPA is converted to dopamine in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study","volume":"195","author":"Arai","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0090","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/syn.20535","article-title":"Reuptake of L-DOPA-derived extracellular DA in the striatum of a rodent model of Parkinson's disease via norepinephrine transporter","volume":"62","author":"Arai","year":"2008","journal-title":"Synapse (New York, N.Y.)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0095","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.expneurol.2008.05.023","article-title":"Altered neuronal activity relationships between the pedunculopontine nucleus and motor cortex in a rodent model of Parkinson's disease","volume":"213","author":"Aravamuthan","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF00176769","article-title":"5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram","volume":"352","author":"Arborelius","year":"1995","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0105","doi-asserted-by":"crossref","first-page":"e42652","DOI":"10.1371\/journal.pone.0042652","article-title":"The role of the subthalamic nucleus in L-DOPA induced dyskinesia in 6-hydroxydopamine lesioned rats","volume":"7","author":"Aristieta","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0110","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s00213-013-3333-0","article-title":"Modulation of the subthalamic nucleus activity by serotonergic agents and fluoxetine administration","volume":"231","author":"Aristieta","year":"2014","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0115","doi-asserted-by":"crossref","first-page":"e106362","DOI":"10.1371\/journal.pone.0106362","article-title":"Striatal astrocytes act as a reservoir for L-DOPA","volume":"9","author":"Asanuma","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0120","series-title":"The rat nervous system","first-page":"259","article-title":"Locus Coeruleus, A5 and A7 noradrenergic cell groups","author":"Aston-Jones","year":"2004"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0125","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/cne.901790311","article-title":"An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat","volume":"179","author":"Azmitia","year":"1978","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0130","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1021\/tx700174w","article-title":"Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol-O-methyltransferases","volume":"20","author":"Bai","year":"2007","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0135","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/cne.10783","article-title":"Overlapping distributions of orexin\/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal motivation, and stress","volume":"464","author":"Baldo","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0140","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1001\/archneurol.2010.35","article-title":"Serotonin 2A receptors and visual hallucinations in Parkinson disease","volume":"67","author":"Ballanger","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0145","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1523\/JNEUROSCI.2010-15.2016","article-title":"Imaging dopamine and serotonin systems on MPTP monkeys: a longitudinal PET investigation of compensatory mechanisms","volume":"36","author":"Ballanger","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0150","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/mds.20124","article-title":"Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease","volume":"19","author":"Bara-Jimenez","year":"2004","journal-title":"Mov. Disord. Off. J. Mov. Dis. Soc."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0155","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/mds.20370","article-title":"Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease","volume":"20","author":"Bara-Jimenez","year":"2005","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0160","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0165","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.pbb.2011.09.009","article-title":"Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by alpha- and beta-adrenergic receptor antagonists in hemiparkinsonian rats","volume":"100","author":"Barnum","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0170","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.2042-7158.1968.tb09726.x","article-title":"Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase","volume":"20","author":"Bartholini","year":"1968","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0175","first-page":"179","article-title":"Immediate-early gene expression in structures outside the basal ganglia is associated to l-DOPA-induced dyskinesia","volume":"62C","author":"Bastide","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0180","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.07.002","article-title":"Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease","volume":"132","author":"Bastide","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0185","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopsych.2014.08.022","article-title":"Inhibiting lateral habenula improves L-DOPA-Induced dyskinesia","volume":"79","author":"Bastide","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0190","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neuropharm.2014.01.031","article-title":"Serotonergic pharmacology in animal models: from behavioral disorders to dyskinesia","volume":"81","author":"Beaudoin-Gobert","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0195","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1093\/brain\/awv183","article-title":"Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate","volume":"138","author":"Beaudoin-Gobert","year":"2015","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0200","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bph.12906","article-title":"Dopamine receptors \u2013 IUPHAR review 13","volume":"172","author":"Beaulieu","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0210","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1212\/WNL.0b013e3182886a76","article-title":"Pedunculopontine nucleus: functional organization and clinical implications","volume":"80","author":"Benarroch","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0215","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-2999(92)90023-W","article-title":"The substituted amphetamines 3,4-methylenedioxymethamphetamine methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine","volume":"215","author":"Berger","year":"1992","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl 4","key":"10.1016\/j.pneurobio.2016.07.002_bib0220","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S1353-8020(09)70827-2","article-title":"Dopamine receptors and L-dopa-induced dyskinesia","volume":"15","author":"Berthet","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0225","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1523\/JNEUROSCI.5884-08.2009","article-title":"Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesia","volume":"29","author":"Berthet","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0230","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.biopsych.2009.04.005","article-title":"Striatal overexpression of DeltaJunD resets L-DOPA-induced dyskinesia in a primate model of Parkinson disease","volume":"66","author":"Berton","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0235","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/brain\/awu407","article-title":"Could the serotonin theory give rise to a treatment for levodopa-induced dyskinesia in Parkinson's disease?","volume":"138","author":"Bezard","year":"2015","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0240","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/mds.23696","article-title":"A tale on animal models of Parkinson's disease","volume":"26","author":"Bezard","year":"2011","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0245","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.neures.2013.10.002","article-title":"Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia","volume":"77","author":"Bezard","year":"2013","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0250","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/mds.25366","article-title":"Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia","volume":"28","author":"Bezard","year":"2013","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0255","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00213-013-3001-4","article-title":"The effects of BMY-14802 against L-DOPA- and dopamine agonist-induced dyskinesia in the hemiparkinsonian rat","volume":"227","author":"Bhide","year":"2013","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0260","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/jnc.13125","article-title":"Effects of the beta-adrenergic receptor antagonist Propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian rat","volume":"134","author":"Bhide","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0265","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1471-4159.2008.05358.x","article-title":"Iron deficiency alters dopamine uptake and response to L-DOPA injection in Sprague-Dawley rats","volume":"106","author":"Bianco","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0270","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1212\/WNL.57.10.1829","article-title":"Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models","volume":"57","author":"Bibbiani","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0275","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1471-4159.2011.07376.x","article-title":"Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels","volume":"118","author":"Bido","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0280","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0149-7634(96)00032-2","article-title":"Dopamine and glutamate control each other's release in the basal ganglia: a microdialysis study of the entopeduncular nucleus and substantia nigra","volume":"21","author":"Biggs","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0285","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/(SICI)1098-2396(199910)34:1<36::AID-SYN5>3.0.CO;2-G","article-title":"Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum","volume":"34","author":"Biggs","year":"1999","journal-title":"Synapse (New York, N.Y.)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0290","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000212871","article-title":"Dopamine action and disorders of neurotransmitter balance","volume":"33","author":"Birkmayer","year":"1987","journal-title":"Gerontology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0295","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1111\/j.1460-9568.2006.04790.x","article-title":"MDMA and fenfluramine reduce L-DOPA-induced dyskinesia via indirect 5-HT1A receptor stimulation","volume":"23","author":"Bishop","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0300","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/jnr.21978","article-title":"Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian rats","volume":"87","author":"Bishop","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0305","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1111\/j.1460-9568.2012.08202.x","article-title":"Serotonin transporter inhibition attenuates l-DOPA-induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats","volume":"36","author":"Bishop","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0310","series-title":"Handbook of Physiology. The Nervous System. IV. Intrinsic Regulatory Systems of the Brain","first-page":"677","article-title":"Catecholaminergic brain stem regulatory systems. Catecholaminergic brain stem regulatory systems","author":"Bj\u00f6rklund","year":"1986"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0315","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.tins.2007.03.006","article-title":"Dopamine neuron systems in the brain: an update","volume":"30","author":"Bjorklund","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2009.10.051","article-title":"Aromatic l-amino acid decarboxylase expression profiling and isoform detection in the developing porcine brain","volume":"1308","author":"Blechingberg","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0325","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fnana.2014.00155","article-title":"Parkinson's disease: animal models and dopaminergic cell vulnerability","volume":"8","author":"Blesa","year":"2014","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0330","doi-asserted-by":"crossref","first-page":"845618","DOI":"10.1155\/2012\/845618","article-title":"Classic and new animal models of Parkinson's disease","volume":"2012","author":"Blesa","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0335","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.nbd.2012.05.018","article-title":"The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study","volume":"48","author":"Blesa","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0340","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00002826-199402000-00008","article-title":"Buspirone in levodopa-induced dyskinesias","volume":"17","author":"Bonifati","year":"1994","journal-title":"Clin. Neuropharmacol."},{"issue":"Suppl 4","key":"10.1016\/j.pneurobio.2016.07.002_bib0345","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/S1353-8020(09)70835-1","article-title":"Role of dopamine receptor agonists in the treatment of early Parkinson's disease","volume":"15","author":"Bonuccelli","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0350","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0035-3787(04)71067-X","article-title":"Central dopamine receptors: general considerations (Part 1)","volume":"160","author":"Bordet","year":"2004","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0355","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.neuron.2015.08.022","article-title":"Loss of striatonigral GABAergic presynaptic inhibition enables motor sensitization in parkinsonian mice","volume":"87","author":"Borgkvist","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0360","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1046\/j.1471-4159.1996.66062546.x","article-title":"Flesinoxan dose-dependently reduces extracellular 5-hydroxytryptamine (5-HT) in rat median raphe and dorsal hippocampus through activation of 5-HT1A receptors","volume":"66","author":"Bosker","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0365","doi-asserted-by":"crossref","first-page":"9575","DOI":"10.1523\/JNEUROSCI.3465-08.2008","article-title":"Behavioral recovery in MPTP-treated monkeys: neurochemical mechanisms studied by intrastriatal microdialysis","volume":"28","author":"Boulet","year":"2008","journal-title":"J. Neurosci."},{"issue":"Suppl 3","key":"10.1016\/j.pneurobio.2016.07.002_bib0370","article-title":"Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages)","volume":"249","author":"Braak","year":"2002","journal-title":"J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0375","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/jb\/mvt110","article-title":"Catalytic domain surface residues mediating catecholamine inhibition in tyrosine hydroxylase","volume":"155","author":"Briggs","year":"2014","journal-title":"J. Biochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0380","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.1523\/JNEUROSCI.0015-10.2010","article-title":"Coding of task reward value in the dorsal raphe nucleus","volume":"30","author":"Bromberg-Martin","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0385","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.neuron.2010.11.022","article-title":"Dopamine in motivational control: rewarding aversive, and alerting","volume":"68","author":"Bromberg-Martin","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0390","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archneurol.2010.260","article-title":"Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues","volume":"68","author":"Bronstein","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0395","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/newbio245123a0","article-title":"Comparison of effects of L-dopa: amphetamine and apomorphine on firing rate of rat dopaminergic neurones","volume":"245","author":"Bunney","year":"1973","journal-title":"Nat. New Biol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0400","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.expneurol.2012.01.011","article-title":"Axon degeneration in Parkinson's disease","volume":"246","author":"Burke","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0405","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/mol.54.2.342","article-title":"Human neurons express the polyspecific cation transporter hOCT2 which translocates monoamine neurotransmitters, amantadine, and memantine","volume":"54","author":"Busch","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0410","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1523\/JNEUROSCI.20-22-08443.2000","article-title":"Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity","volume":"20","author":"Calabresi","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0415","first-page":"593","article-title":"Low dose levodopa in schizophrenia","volume":"1","author":"Calil","year":"1977","journal-title":"Commun. Psychopharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0420","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pnpbp.2015.08.013","article-title":"The effect of striatal dopamine depletion on striatal and cortical glutamate: a mini-review","volume":"65","author":"Caravaggio","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0425","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0166-2236(90)90108-M","article-title":"Interactions between glutamatergic and monoaminergic systems within the basal ganglia\u2013implications for schizophrenia and Parkinson's disease","volume":"13","author":"Carlsson","year":"1990","journal-title":"Trends Neurosci."},{"issue":"4596","key":"10.1016\/j.pneurobio.2016.07.002_bib0430","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/1801200a0","article-title":"3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists","volume":"180","author":"Carlsson","year":"1957","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0435","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuroscience.2011.07.070","article-title":"Contribution of pre-synaptic mechanisms to L-DOPA-induced dyskinesia","volume":"198","author":"Carta","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0440","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1111\/j.1471-4159.2006.03696.x","article-title":"Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats","volume":"96","author":"Carta","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0445","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/brain\/awm082","article-title":"Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats","volume":"130","author":"Carta","year":"2007","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0450","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1046\/j.1471-4159.1996.67051945.x","article-title":"Differential effects of ipsapirone on 5-hydroxytryptamine release in the dorsal and median raphe neuronal pathways","volume":"67","author":"Casanovas","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0455","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.expneurol.2015.09.002","article-title":"Depressive-like phenotype induced by AAV-mediated overexpression of human alpha-synuclein in midbrain dopaminergic neurons","volume":"273","author":"Caudal","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0460","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archneur.1970.00480270003001","article-title":"Psychosis and other psychiatric manifestations of levodopa therapy","volume":"23","author":"Celesia","year":"1970","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0465","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/brain\/awu329","article-title":"A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias","volume":"138","author":"Cerasa","year":"2015","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0470","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0854.2010.01125.x","article-title":"Selective recapture of secretory granule components after full collapse exocytosis in neuroendocrine chromaffin cells","volume":"12","author":"Ceridono","year":"2011","journal-title":"Traffic (Copenhagen, Denmark)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0475","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1073\/pnas.68.3.662","article-title":"Effects of L-dopa on norepinephrine metabolism in the brain","volume":"68","author":"Chalmers","year":"1971","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0480","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.expneurol.2011.09.029","article-title":"L-DOPA is incorporated into brain proteins of patients treated for Parkinson's disease: inducing toxicity in human neuroblastoma cells in vitro","volume":"238","author":"Chan","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0485","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1523\/JNEUROSCI.5231-13.2015","article-title":"Gene expression analyses identify Narp contribution in the development of L-DOPA-induced dyskinesia","volume":"35","author":"Charbonnier-Beaupel","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0490","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/S0024-3205(00)00543-9","article-title":"Effects of dopamine metabolites on locomotor activities and on the binding of dopamine: relevance to the side effects of L-dopa","volume":"66","author":"Charlton","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0495","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1212\/WNL.50.5_Suppl_5.S17","article-title":"Levodopa therapy: consequences of the nonphysiologic replacement of dopamine","volume":"50","author":"Chase","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0500","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0166-2236(96)10052-7","article-title":"Basal ganglia and movement disorders: an update","volume":"19","author":"Chesselet","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0505","doi-asserted-by":"crossref","first-page":"e52322","DOI":"10.1371\/journal.pone.0052322","article-title":"Dopamine transporter loss in 6-OHDA Parkinson's model is unmet by parallel reduction in dopamine uptake","volume":"7","author":"Chotibut","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0510","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1124\/mol.114.093302","article-title":"Norepinephrine transporter inhibition with desipramine exacerbates L-DOPA-induced dyskinesia: role for synaptic dopamine regulation in denervated nigrostriatal terminals","volume":"86","author":"Chotibut","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0515","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1476-5381.1990.tb13000.x","article-title":"Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle","volume":"99","author":"Commissiong","year":"1990","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2013.09.017","article-title":"Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats","volume":"77","author":"Conti","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0525","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pbb.2016.01.004","article-title":"Effect of tricyclic antidepressants on L-DOPA-induced dyskinesia and motor improvement in hemi-parkinsonian rats","volume":"142","author":"Conti","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0530","series-title":"The Biochemical Basis of Neuropharmacology: New York","author":"Cooper","year":"2003"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0535","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neulet.2014.11.023","article-title":"Chronic levodopa treatment alters expression and function of dopamine D3 receptor in the MPTP\/p mouse model of Parkinson's disease","volume":"585","author":"Cote","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0540","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbr.2014.01.011","article-title":"Overexpression of the dopamine D3 receptor in the rat dorsal striatum induces dyskinetic behaviors","volume":"263","author":"Cote","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0545","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJM196902132800701","article-title":"Modification of parkinsonism?chronic treatment with L-dopa","volume":"280","author":"Cotzias","year":"1969","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0550","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0006-8993(96)01227-9","article-title":"The effect of unilateral neurotoxic lesions to serotonin fibres in the medial forebrain bundle on the metabolism of [3H]DOPA in the telencephalon of the living rat","volume":"747","author":"Cumming","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0555","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(13)62106-6","article-title":"Pimavanserin for patients with Parkinson's disease psychosis: a randomised placebo-controlled phase 3 trial","volume":"383","author":"Cummings","year":"2014","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0560","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/BF02147990","article-title":"Localization of monoamines in the lower brain stem","volume":"20","author":"Dahlstrom","year":"1964","journal-title":"Experientia"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0565","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.neuron.2011.01.020","article-title":"Impulsivity compulsivity, and top-down cognitive control","volume":"69","author":"Dalley","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0570","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/mds.1091","article-title":"Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions","volume":"16","author":"Datla","year":"2001","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0575","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0580","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1523\/JNEUROSCI.5071-13.2014","article-title":"A major external source of cholinergic innervation of the striatum and nucleus accumbens originates in the brainstem","volume":"34","author":"Dautan","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0585","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0028-3908(03)00190-4","article-title":"L-DOPA increases noradrenaline turnover in central and peripheral nervous systems","volume":"45","author":"Dayan","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0590","article-title":"Chronic L-DOPA alters the activity of monoamine oxidase in vivo","author":"De Deurwaerd\u00e8re","year":"2014","journal-title":"Neuropatho. Neuropharmacol. Monoaminergic Syst."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0595","article-title":"Serotonergic modulation of the activity of mesencephalic dopaminergic systems: therapeutic implications","author":"De Deurwaerdere","year":"2016","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurol.2012.01.585","article-title":"What can we expect from the serotonergic side of l-DOPA?","author":"De Deurwaerdere","year":"2012","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0605","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1046\/j.1471-4159.1995.65031100.x","article-title":"d-fenfluramine increases striatal extracellular dopamine in vivo independently of serotonergic terminals or dopamine uptake sites","volume":"65","author":"De Deurwaerdere","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0610","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1046\/j.1471-4159.1996.66010210.x","article-title":"Serotonin enhances striatal dopamine outflow in vivo through dopamine uptake sites","volume":"66","author":"De Deurwaerdere","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0615","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0006-8993(93)91459-6","article-title":"Differential effect of systemic administration of bromocriptine and L-dopa on the release of acetylcholine from striatum of intact and 6-OHDA-treated rats","volume":"608","author":"DeBoer","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0620","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0166-2236(90)90110-V","article-title":"Primate models of movement disorders of basal ganglia origin","volume":"13","author":"DeLong","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0625","article-title":"Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson\u2019s disease","author":"Deane","year":"2004","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0630","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.nbd.2011.12.013","article-title":"Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons","volume":"45","author":"Decressac","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0635","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnsys.2011.00031","article-title":"Noradrenaline and Parkinson's disease","volume":"5","author":"Delaville","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0640","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1093\/brain\/awh290","article-title":"Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias","volume":"127","author":"de la Fuente-Fernandez","year":"2004","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0645","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fneur.2013.00090","article-title":"Imaging of dopamine in PD and implications for motor and neuropsychiatric manifestations of PD","volume":"4","author":"de la Fuente-Fernandez","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0650","first-page":"161","article-title":"Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2","volume":"35","author":"del Amo","year":"2008","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0655","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s007020050147","article-title":"Pergolide potentiates L-DOPA-induced dopamine release in rat striatum after lesioning with 6-hydroxydopamine","volume":"106","author":"Dethy","year":"1999","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0660","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2202-6-31","article-title":"Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus","volume":"6","author":"Devoto","year":"2005","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0665","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/jnr.21611","article-title":"6-Hydroxydopamine lesion in the ventral tegmental area fails to reduce extracellular dopamine in the cerebral cortex","volume":"86","author":"Devoto","year":"2008","journal-title":"J. Neurosci. Res."},{"issue":"Suppl","key":"10.1016\/j.pneurobio.2016.07.002_bib0670","first-page":"231s","article-title":"Heterologous monoamine reuptake: lack of transmitter specificity of neuron-specific carriers","volume":"20","author":"Di Chiara","year":"1992","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0675","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0166-2236(94)90005-1","article-title":"Modulatory functions of neurotransmitters in the striatum: aCh\/dopamine\/NMDA interactions","volume":"17","author":"Di Chiara","year":"1994","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0680","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1212\/01.WNL.0000031424.51127.2B","article-title":"Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET study","volume":"60","author":"Doder","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0685","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0014-2999(76)90308-3","article-title":"Modification of the L-DOPA reversal of reserpine akinesia by inhibitors of dopamine-beta-hydroxylase","volume":"35","author":"Dolphin","year":"1976","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0690","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0091-3057(76)90107-6","article-title":"Noradrenaline synthesis from L-DOPA in rodents and its relationship to motor activity","volume":"5","author":"Dolphin","year":"1976","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0695","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1093\/brain\/awu131","article-title":"Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons","volume":"137","author":"Dragicevic","year":"2014","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0700","doi-asserted-by":"crossref","first-page":"12444","DOI":"10.1523\/JNEUROSCI.1458-14.2014","article-title":"Three mechanisms by which striatal denervation causes breakdown of dopamine signaling","volume":"34","author":"Dreyer","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0705","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1124\/jpet.110.170142","article-title":"Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3","volume":"335","author":"Duan","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0710","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainres.2007.05.005","article-title":"The differential effects of 5-HT(1A) receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat","volume":"1158","author":"Dupre","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0715","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00213-008-1135-6","article-title":"Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on L-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat","volume":"199","author":"Dupre","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0720","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.expneurol.2011.02.012","article-title":"Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic: hemiparkinsonian rats","volume":"229","author":"Dupre","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0725","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1212\/WNL.45.10.1855","article-title":"Levodopa-induced dyskinesias are improved by fluoxetine","volume":"45","author":"Durif","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0730","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1212\/WNL.48.3.658","article-title":"Low-dose clozapine improves dyskinesias in Parkinson's disease","volume":"48","author":"Durif","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0735","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1212\/01.WNL.0000110317.52453.6C","article-title":"Clozapine improves dyskinesias in Parkinson disease: a double-blind placebo-controlled study","volume":"62","author":"Durif","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0740","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/pr.56.3.1","article-title":"Catecholamine metabolism: a contemporary view with implications for physiology and medicine","volume":"56","author":"Eisenhofer","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0745","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuropharm.2014.05.024","article-title":"NMDA receptor antagonism potentiates the L-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats","volume":"85","author":"El Arfani","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0750","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neuint.2015.07.005","article-title":"Alterations in the motor cortical and striatal glutamatergic system and D-serine levels in the bilateral 6-hydroxydopamine rat model for Parkinson's disease","volume":"88","author":"El Arfani","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0755","doi-asserted-by":"crossref","first-page":"50042","DOI":"10.1074\/jbc.M407913200","article-title":"Identification and characterization of a novel monoamine transporter in the human brain","volume":"279","author":"Engel","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0760","first-page":"2783","article-title":"Widespread monoaminergic dysregulation of both motor and non-Motor circuits in parkinsonism and dyskinesia","volume":"25","author":"Engeln","year":"2015","journal-title":"Cereb. Cortex (New York, N.Y.: 1991)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0765","first-page":"877","article-title":"Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type","volume":"289","author":"Eshleman","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0770","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/FBP.0b013e32833e7e80","article-title":"Behavioral and neurochemical effects of chronic L-DOPA treatment on nonmotor sequelae in the hemiparkinsonian rat","volume":"21","author":"Eskow Jaunarajs","year":"2010","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0775","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.neubiorev.2010.06.007","article-title":"Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment","volume":"35","author":"Eskow Jaunarajs","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0780","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pneurobio.2015.02.002","article-title":"Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia","volume":"127\u2013128","author":"Eskow Jaunarajs","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0785","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pbb.2007.05.002","article-title":"The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy","volume":"87","author":"Eskow","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0790","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/syn.20630","article-title":"The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats","volume":"63","author":"Eskow","year":"2009","journal-title":"Synapse (New York, N.Y.)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0795","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1586\/14737175.7.6.677","article-title":"Death in the substantia nigra: a motor tragedy","volume":"7","author":"Esposito","year":"2007","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0800","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1126\/science.168.3933.849","article-title":"L-DOPA: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice","volume":"168","author":"Everett","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0805","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.nbd.2015.07.010","article-title":"The combined depletion of monoamines alters the effectiveness of subthalamic deep brain stimulation","volume":"82","author":"Faggiani","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0810","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0022-510X(71)90178-X","article-title":"Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson's disease and their role in akinesia rigidity, chorea, and tremor","volume":"14","author":"Fahn","year":"1971","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0815","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1056\/NEJMoa033447","article-title":"Levodopa and the progression of Parkinson's disease","volume":"351","author":"Fahn","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 4","key":"10.1016\/j.pneurobio.2016.07.002_bib0820","first-page":"Iv37","article-title":"Does levodopa slow or hasten the rate of progression of Parkinson's disease?","volume":"254","author":"Fahn","year":"2005","journal-title":"J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0825","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/1531-8257(199905)14:3<484::AID-MDS1016>3.0.CO;2-B","article-title":"Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease","volume":"14","author":"Fernandez","year":"1999","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0830","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.10374","article-title":"Long-term outcome of quetiapine use for psychosis among Parkinsonian patients","volume":"18","author":"Fernandez","year":"2003","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0835","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.neures.2003.08.001","article-title":"Effects of orally administered levodopa on mesencephalic dopaminergic neurons undergoing a degenerative process","volume":"47","author":"Ferrario","year":"2003","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0840","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/ene.12666","article-title":"Effect of opicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity and motor fluctuations in patients with Parkinson's disease","volume":"22","author":"Ferreira","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0845","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.neuroscience.2015.04.027","article-title":"Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's disease","volume":"298","author":"Fidalgo","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0850","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0306-4522(99)00406-6","article-title":"Dual effects of L-3,4-dihydroxyphenylalanine on aromatic L-amino acid decarboxylase: dopamine release and motor stimulation in the reserpine-treated rat: evidence that behaviour is dopamine independent","volume":"95","author":"Fisher","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0855","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neuroscience.2013.09.059","article-title":"Monoamines tissue content analysis reveals restricted and site-specific correlations in brain regions involved in cognition","volume":"255","author":"Fitoussi","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0860","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.1523\/JNEUROSCI.3080-04.2004","article-title":"Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein","volume":"24","author":"Fleming","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0865","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)11597-P","article-title":"5-Hydroxytryptamine increases spontaneous activity of subthalamic neurons in the rat","volume":"192","author":"Flores","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0870","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/j.1460-9568.2007.05360.x","article-title":"High-frequency stimulation of the subthalamic nucleus modulates the activity of pedunculopontine neurons through direct activation of excitatory fibres as well as through indirect activation of inhibitory pallidal fibres in the rat","volume":"25","author":"Florio","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0875","first-page":"1","article-title":"The L-DOPA story revisited. Further surprises to be expected?","author":"Foley","year":"2000","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0880","first-page":"595","article-title":"Glial D-serine gates NMDA receptors at excitatory synapses in prefrontal cortex","volume":"22","author":"Fossat","year":"2012","journal-title":"Cereb. Cortex (New York, N.Y.: 1991)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0885","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0079-6123(10)84007-5","article-title":"The MPTP-lesioned non-human primate models of Parkinson's disease. Past present, and future","volume":"184","author":"Fox","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0890","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/mds.1148","article-title":"Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan","volume":"16","author":"Fox","year":"2001","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0895","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/1531-8257(200003)15:2<201::AID-MDS1001>3.0.CO;2-D","article-title":"Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease","volume":"15","author":"Friedman","year":"2000","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0900","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1755-5949.2010.00206.x","article-title":"Neuroprotection in parkinson's disease: a realistic goal?","volume":"16","author":"Galati","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0905","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1046\/j.1460-9568.2003.02795.x","article-title":"The effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis","volume":"18","author":"Galeffi","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0910","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.celrep.2015.07.005","article-title":"Depression of serotonin synaptic transmission by the dopamine precursor L-DOPA","volume":"12","author":"Gantz","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0915","series-title":"Anatomy of the Noradrenergic Pathways in the Primate Brain Alteration in Parkinson's Disease","first-page":"73","author":"Gaspar","year":"1994"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0920","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/j.1476-5381.1996.tb15309.x","article-title":"5-HT4 receptor-mediated modulation of 5-HT release in the rat hippocampus in vivo","volume":"117","author":"Ge","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0925","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1523\/JNEUROSCI.07-12-03915.1987","article-title":"The neostriatal mosaic: II: Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems","volume":"7","author":"Gerfen","year":"1987","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0930","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","article-title":"D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons","volume":"250","author":"Gerfen","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0935","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s00702-010-0571-8","article-title":"Role of dopamine D3 and serotonin 5-HT 1A receptors in L: -DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease","volume":"118","author":"Gerlach","year":"2011","journal-title":"J. Neural Transm. (Vienna, Austria: 1996)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0940","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00702-012-0818-7","article-title":"The effect of piribedil on L-DOPA-induced dyskinesias in a rat model of Parkinson's disease: differential role of alpha(2) adrenergic mechanisms","volume":"120","author":"Gerlach","year":"2013","journal-title":"J. Neural Transm. (Vienna, Austria: 1996)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0945","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s10571-010-9509-9","article-title":"The roles of striatal serotonin and L-amino-acid decarboxylase on L-DOPA-induced Dyskinesia in a Hemiparkinsonian rat model","volume":"30","author":"Gil","year":"2010","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0950","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0278-5846(83)90109-4","article-title":"Combined administration of direct dopamine receptor agonists and L-dopa does not interfere with utilization of exogenous L-dopa in rat corpus striatum","volume":"7","author":"Globus","year":"1983","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0955","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0306-4522(97)00565-4","article-title":"Simultaneous quantification of serotonin: dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release","volume":"84","author":"Gobert","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0960","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0306-4522(99)00211-0","article-title":"Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine: noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions","volume":"93","author":"Gobert","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0965","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jneumeth.2004.04.040","article-title":"Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by alpha2-autoreceptors","volume":"140","author":"Gobert","year":"2004","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0970","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/mds.21226","article-title":"Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial","volume":"22","author":"Goetz","year":"2007","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0975","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/mds.21897","article-title":"Placebo influences on dyskinesia in Parkinson's disease","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0980","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/jnc.12345","article-title":"Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease","volume":"126","author":"Goldstein","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0985","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.parkreldis.2015.03.006","article-title":"Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy","volume":"21","author":"Goldstein","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0990","first-page":"235","article-title":"Biomarkers, mechanisms, and potential prevention of catecholamine neuron loss in Parkinson disease","volume":"68","author":"Goldstein","year":"2013","journal-title":"Adv. Pharmacol. (San Diego, Calif.)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib0995","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s12640-011-9263-x","article-title":"Effect of adenosine A(2A) receptor antagonists and L-DOPA on hydroxyl radical: glutamate and dopamine in the striatum of 6-OHDA-treated rats","volume":"21","author":"Golembiowska","year":"2012","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1000","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/00002826-199310000-00004","article-title":"Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys","volume":"16","author":"Gomez-Mancilla","year":"1993","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1005","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0006-2952(82)90194-0","article-title":"Substrate stereospecificity and selectivity of catechol-O-methyltransferase for DOPA: DOPA derivatives and alpha-substituted catecholamines","volume":"31","author":"Gordonsmith","year":"1982","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1010","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1476-5381.1986.tb11139.x","article-title":"Biphasic actions of L-DOPA on the release of endogenous noradrenaline and dopamine from rat hypothalamic slices","volume":"89","author":"Goshima","year":"1986","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1015","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1111\/j.1471-4159.1988.tb02470.x","article-title":"Transmitter-like release of endogenous 3 4-dihydroxyphenylalanine from rat striatal slices","volume":"50","author":"Goshima","year":"1988","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1254\/jjp.53.47","article-title":"L-dopa facilitates the release of endogenous norepinephrine and dopamine via presynaptic beta 1- and beta 2-adrenoceptors under essentially complete inhibition of L-aromatic amino acid decarboxylase in rat hypothalamic slices","volume":"53","author":"Goshima","year":"1990","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0021-5198(19)39981-0","volume":"55","author":"Goshima","year":"1991","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1030","first-page":"466","article-title":"L-dihydroxyphenylalanine methyl ester is a potent competitive antagonist of the L-dihydroxyphenylalanine-induced facilitation of the evoked release of endogenous norepinephrine from rat hypothalamic slices","volume":"258","author":"Goshima","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0006-8993(93)90631-V","article-title":"L-dopa induces Ca(2+)-dependent and tetrodotoxin-sensitive release of endogenous glutamate from rat striatal slices","volume":"617","author":"Goshima","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1040","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s002109900167","article-title":"Noradrenoceptor antagonism with idazoxan improves L-dopa-induced dyskinesias in MPTP monkeys","volume":"361","author":"Grondin","year":"2000","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1045","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1016\/S0021-9258(17)37256-3","article-title":"Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity kinetics, and ion dependence","volume":"269","author":"Gu","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1050","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.expneurol.2013.02.009","article-title":"Dual effects of L-DOPA on nigral dopaminergic neurons","volume":"247","author":"Guatteo","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1055","first-page":"625","article-title":"Functional interactions between dopamine: serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions","volume":"11","author":"Guiard","year":"2008","journal-title":"Int. J. Neuropsychopharmacol. Off. Sci. J. Collegium Int. Neuropsychopharm."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1060","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.nbd.2007.02.001","article-title":"Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates","volume":"26","author":"Guigoni","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1065","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1432-1033.1978.tb12467.x","article-title":"The purification and properties of pig-liver catechol-O-methyl transferase","volume":"88","author":"Gulliver","year":"1978","journal-title":"Eur. J. Biochem.\/FEBS"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrn1034","article-title":"The role of histamine and the tuberomamillary nucleus in the nervous system","volume":"4","author":"Haas","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1075","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1046\/j.1471-4159.1997.69041720.x","article-title":"L-DOPA is a substrate for tyrosine hydroxylase","volume":"69","author":"Haavik","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1080","doi-asserted-by":"crossref","first-page":"e91545","DOI":"10.1371\/journal.pone.0091545","article-title":"An eight-year clinic experience with clozapine use in a Parkinson's disease clinic setting","volume":"9","author":"Hack","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1085","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1755-5949.2008.00058.x","article-title":"Enhancing aromatic L-amino acid decarboxylase activity: implications for L-DOPA treatment in Parkinson's disease","volume":"14","author":"Hadjiconstantinou","year":"2008","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00210-009-0479-8","article-title":"Interaction of the human plasma membrane monoamine transporter (hPMAT) with antidepressants and antipsychotics","volume":"381","author":"Haenisch","year":"2010","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1095","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/npp.2014.295","article-title":"Involvement of cholinergic system in hyperactivity in dopamine-deficient mice","volume":"40","author":"Hagino","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1100","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0306-4522(98)00157-2","article-title":"An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat","volume":"87","author":"Hajos","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00213-010-2089-z","article-title":"Functional topography of midbrain and pontine serotonergic systems: implications for synaptic regulation of serotonergic circuits","volume":"213","author":"Hale","year":"2011","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1110","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0006-8993(90)90733-R","article-title":"Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease","volume":"510","author":"Halliday","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/07391102.2007.10507165","article-title":"Effect of Cl- on tyrosinase: complex inhibition kinetics and biochemical implication","volume":"25","author":"Han","year":"2007","journal-title":"J. Biomol. Struct. Dynam."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1120","doi-asserted-by":"crossref","first-page":"6157","DOI":"10.1523\/JNEUROSCI.15-09-06157.1995","article-title":"Activation of dopamine cell firing by repeated L-DOPA administration to dopamine-depleted rats: its potential role in mediating the therapeutic response to L-DOPA treatment","volume":"15","author":"Harden","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1125","article-title":"Fast-scan cyclic voltammetry demonstrates that L-DOPA produces dose-dependent regionally selective, bimodal effects on striatal dopamine kinetics in vivo","author":"Harun","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000215875","article-title":"Levodopa: past present, and future","volume":"62","author":"Hauser","year":"2009","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbr.2014.01.014","article-title":"High frequency stimulation of subthalamic nucleus results in behavioral recovery by increasing striatal dopamine release in 6-hydroxydopamine lesioned rat","volume":"263","author":"He","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1140","first-page":"189","article-title":"The site of dopamine formation in rat striatum after L-dopa administration","volume":"217","author":"Hefti","year":"1981","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1145","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/1531-8257(199909)14:5<744::AID-MDS1006>3.0.CO;2-7","article-title":"The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease","volume":"14","author":"Henry","year":"1999","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1150","first-page":"167","article-title":"Catecholamine\/Serotonin interactions: systems thinking for brain function and disease","volume":"68","author":"Hensler","year":"2013","journal-title":"Adv. Pharmacol. (San Diego, Calif.)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1155","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1007\/s00415-013-7126-5","article-title":"Levels of HVA 5-HIAA, and MHPG in the CSF of vascular parkinsonism compared to Parkinson's disease and controls","volume":"260","author":"Herbert","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1160","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0006-8993(79)91033-3","article-title":"Effect of nerve activity on the in vivo release of [3H]serotonin continuously formed from L-[3H]tryptophan in the caudate nucleus of the cat","volume":"169","author":"Hery","year":"1979","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1165","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ana.24138","article-title":"The acute brain response to levodopa heralds dyskinesias in Parkinson disease","volume":"75","author":"Herz","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1170","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/brain\/awv096","article-title":"Abnormal dopaminergic modulation of striato-cortical networks underlies levodopa-induced dyskinesias in humans","volume":"138","author":"Herz","year":"2015","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1175","first-page":"189","article-title":"Parkinson's disease: carbidopa nausea, and dyskinesia","volume":"6","author":"Hinz","year":"2014","journal-title":"Clin. Pharmacol. Adv. Appl."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neubiorev.2014.11.010","article-title":"Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease","volume":"49","author":"Hirao","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1185","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/bph.12459","article-title":"The protein Ocular albinism 1 is the orphan GPCR GPR143 and mediates depressor and bradycardic responses to DOPA in the nucleus tractus solitarii","volume":"171","author":"Hiroshima","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"Suppl 2","key":"10.1016\/j.pneurobio.2016.07.002_bib1190","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1017\/S0317167100000068","article-title":"Ropinirole and pramipexole: the new agonists","volume":"26","author":"Hobson","year":"1999","journal-title":"Can. J. Neurol. Sci. Le Journal Canadien Des Sciences Neurologiques"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1195","first-page":"37","article-title":"Role of monoamine neural systems in L-dihydroxyphenylalanine-stimulated activity","volume":"208","author":"Hollister","year":"1979","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1200","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/oxfordjournals.bmb.a070990","article-title":"Dopamine in the basal ganglia: its role and therapeutic implications (including the clinical use of L-DOPA)","volume":"29","author":"Hornykiewicz","year":"1973","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1205","first-page":"9","article-title":"The discovery of dopamine deficiency in the parkinsonian brain","author":"Hornykiewicz","year":"2006","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1210","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00221-013-3621-2","article-title":"The serotonergic system in motor and non-motor manifestations of Parkinson's disease","volume":"230","author":"Huot","year":"2013","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1215","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pneurobio.2011.08.004","article-title":"The serotonergic system in Parkinson's disease","volume":"95","author":"Huot","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1220","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.neuropharm.2012.06.012","article-title":"L-DOPA pharmacokinetics in the MPTP-lesioned macaque model of Parkinson's disease","volume":"63","author":"Huot","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1225","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.neurobiolaging.2010.04.035","article-title":"5-HT2A receptor levels increase in MPTP-lesioned macaques treated chronically with L-DOPA","volume":"33","author":"Huot","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1230","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/pr.111.005678","article-title":"The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease","volume":"65","author":"Huot","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1235","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neuropharm.2015.05.033","article-title":"The highly-selective 5-HT(1A) agonist F15599 reduces L-DOPA-induced dyskinesia without compromising anti-parkinsonian benefits in the MPTP-lesioned macaque","volume":"97","author":"Huot","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1240","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.0953-816x.2001.01856.x","article-title":"Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice","volume":"15","author":"Huotari","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1245","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.neuroscience.2015.01.057","article-title":"Blood withdrawal affects iron store dynamics in primates with consequences on monoaminergic system function","volume":"290","author":"Hyacinthe","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1250","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0893-133X(01)00312-8","article-title":"Atypical but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum","volume":"26","author":"Ichikawa","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1255","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neuropharm.2015.01.012","article-title":"Activity of serotonin 5-HT(1A) receptor \u2018biased agonists' in rat models of Parkinson's disease and L-DOPA-induced dyskinesia","volume":"93","author":"Iderberg","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1260","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.expneurol.2015.05.021","article-title":"NLX-112: a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: behavioral and neurochemical profile in rat","volume":"271","author":"Iderberg","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1265","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3940(99)00409-7","article-title":"Tyrosine hydroxylase and aromatic L-amino acid decarboxylase do not coexist in neurons in the human anterior cingulate cortex","volume":"269","author":"Ikemoto","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1270","doi-asserted-by":"crossref","first-page":"9107","DOI":"10.1523\/JNEUROSCI.23-27-09107.2003","article-title":"3,4-methylenedioxymethamphetamine (ecstasy) inhibits dyskinesia expression and normalizes motor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates","volume":"23","author":"Iravani","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1275","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1124\/jpet.106.110429","article-title":"In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: the selective 5-hydroxytryptamine 1a agonist (R)-(+)-8-OHDPAT inhibits levodopa-induced dyskinesia but only with\\ increased motor disability","volume":"319","author":"Iravani","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1280","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/S0028-3908(00)00092-7","article-title":"Inhibition of the 5-HT(1A) receptor-mediated inwardly rectifying K(+) current by dextromethorphan in rat dorsal raphe neurones","volume":"39","author":"Ishibashi","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1285","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.pnpbp.2004.05.034","article-title":"Noradrenaline storage function of species-specific protein bodies: markers of monoamine neurons in human locus coeruleus demonstrated by dopamine-beta-hydroxylase immunogold localization","volume":"28","author":"Issidorides","year":"2004","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1290","first-page":"912","article-title":"Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine","volume":"267","author":"Jackson","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1295","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1152\/physrev.1992.72.1.165","article-title":"Structure and function of the brain serotonin system","volume":"72","author":"Jacobs","year":"1992","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1300","first-page":"563","article-title":"Activity of brain serotonergic neurons in the behaving animal","volume":"43","author":"Jacobs","year":"1991","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1305","doi-asserted-by":"crossref","first-page":"9S","DOI":"10.1016\/S0893-133X(99)00012-3","article-title":"Activity of serotonergic neurons in behaving animals","volume":"21","author":"Jacobs","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1310","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1471-4159.1996.66010014.x","article-title":"Alternate promoters in the rat aromatic L-amino acid decarboxylase gene for neuronal and nonneuronal expression: an in situ hybridization study","volume":"66","author":"Jahng","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1315","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/WNR.0b013e3283300fd7","article-title":"Serotonin 1B receptor stimulation reduces D1 receptor agonist-induced dyskinesia","volume":"20","author":"Jaunarajs","year":"2009","journal-title":"Neuroreport"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1320","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/prep.1997.0778","article-title":"Expression purification, and characterization of rat aromatic L-amino acid decarboxylase in Escherichia coli","volume":"11","author":"Jebai","year":"1997","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1325","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF03159935","article-title":"Pathology of Parkinson's disease: changes other than the nigrostriatal pathway","volume":"14","author":"Jellinger","year":"1991","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1330","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1001\/jama.1970.03170260061021","article-title":"Psychic effects in patients treated with levodopa","volume":"212","author":"Jenkins","year":"1970","journal-title":"JAMA"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1335","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1212\/WNL.50.6_Suppl_6.S39","article-title":"Levodopa neurotoxicity: experimental studies versus clinical relevance","volume":"50","author":"Jenner","year":"1998","journal-title":"Neurology"},{"issue":"Suppl 2","key":"10.1016\/j.pneurobio.2016.07.002_bib1340","doi-asserted-by":"crossref","first-page":"277S","DOI":"10.1111\/j.1365-2125.1983.tb05876.x","article-title":"Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease","volume":"15","author":"Jenner","year":"1983","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"Suppl","key":"10.1016\/j.pneurobio.2016.07.002_bib1345","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1002\/ana.410320714","article-title":"Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group","volume":"32","author":"Jenner","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1350","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00702-011-0703-9","article-title":"Continuous drug delivery in early- and late-stage Parkinson's disease as a strategy for avoiding dyskinesia induction and expression","volume":"118","author":"Jenner","year":"2011","journal-title":"J. Neural Transm. (Vienna, Austria: 1996)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1355","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrn2471","article-title":"Molecular mechanisms of L-DOPA-induced dyskinesia","volume":"9","author":"Jenner","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1360","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s007020170056","article-title":"Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat","volume":"108","author":"Jonkers","year":"2001","journal-title":"J. Neural Transm. (Vienna, Austria: 1996)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1365","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0006-8993(01)03147-X","article-title":"MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats","volume":"926","author":"Jonkers","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1370","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.coph.2006.11.004","article-title":"Dopamine D3 receptor agonists for protection and repair in Parkinson's disease","volume":"7","author":"Joyce","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1375","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/j.1476-5381.2009.00494.x","article-title":"Importance of membrane-bound catechol-O-methyltransferase in L-DOPA metabolism: a pharmacokinetic study in two types of Comt gene modified mice","volume":"158","author":"Kaenmaki","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1380","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0006-8993(00)02758-X","article-title":"The 4F2hc\/LAT1 complex transports L-DOPA across the blood-brain barrier","volume":"879","author":"Kageyama","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1385","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2174\/1389200013338324","article-title":"Heterodimeric amino acid transporters: molecular biology and pathological and pharmacological relevance","volume":"2","author":"Kanai","year":"2001","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1390","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1471-4159.2000.0740263.x","article-title":"Reserpine pretreatment prevents increases in extracellular striatal dopamine following L-DOPA administration in rats with nigrostriatal denervation","volume":"74","author":"Kannari","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1395","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1046\/j.1471-4159.2001.00184.x","article-title":"Activation of 5-HT(1A) but not 5-HT(1B) receptors attenuates an increase in extracellular dopamine derived from exogenously administered L-DOPA in the striatum with nigrostriatal denervation","volume":"76","author":"Kannari","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1400","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neulet.2006.03.059","article-title":"Reuptake of L-DOPA-derived extracellular dopamine in the striatum with dopaminergic denervation via serotonin transporters","volume":"402","author":"Kannari","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1405","first-page":"10","article-title":"How antipsychotics work-from receptors to reality","volume":"3","author":"Kapur","year":"2006","journal-title":"NeuroRx J. Am. Soc. Exp. NeuroTher."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1410","first-page":"295","article-title":"Low dose quetiapine for drug induced dyskinesias in Parkinson's disease: a double blind cross over study","volume":"75","author":"Katzenschlager","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1415","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0166-2236(95)98374-8","article-title":"Striatal interneurones: chemical: physiological and morphological characterization","volume":"18","author":"Kawaguchi","year":"1995","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1420","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1017\/erm.2015.6","article-title":"Viral vector delivery of neurotrophic factors for Parkinson's disease therapy","volume":"17","author":"Kelly","year":"2015","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1425","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/archneur.60.9.1223","article-title":"Positron emission tomography of striatal serotonin transporters in Parkinson disease","volume":"60","author":"Kerenyi","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1430","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1211\/0022357011775794","article-title":"Molecular and functional identification of large neutral amino acid transporters LAT1 and LAT2 and their pharmacological relevance at the blood-brain barrier","volume":"53","author":"Kido","year":"2001","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1435","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","article-title":"Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system","volume":"22","author":"Kirik","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1440","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1073\/pnas.0536383100","article-title":"Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease","volume":"100","author":"Kirik","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1445","first-page":"120","article-title":"Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease","volume":"131","author":"Kish","year":"2008","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1450","first-page":"39","article-title":"Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?","volume":"91","author":"Kish","year":"2003","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1455","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0304-3940(88)90630-1","article-title":"Endogenous L-dopa: its immunoreactivity in neurons of midbrain and its projection fields in the cat","volume":"95","author":"Kitahama","year":"1988","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1460","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1523\/JNEUROSCI.4080-10.2011","article-title":"A genetically defined morphologically and functionally unique subset of 5-HT neurons in the mouse raphe nuclei","volume":"31","author":"Kiyasova","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1465","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00002826-200301000-00003","article-title":"Clozapine in Parkinson's disease psychosis: 5-year follow-up review","volume":"26","author":"Klein","year":"2003","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1470","first-page":"1111","article-title":"Regulation of extracellular concentrations of 5-hydroxytryptamine (5-HT) in mouse striatum by 5-HT(1A) and 5-HT(1B) receptors","volume":"292","author":"Knobelman","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1475","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neulet.2014.02.027","article-title":"Effects of L-tryptophan on L-DOPA-induced dyskinesia in the L-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque model of Parkinson's disease","volume":"566","author":"Ko","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1480","doi-asserted-by":"crossref","first-page":"29175","DOI":"10.1074\/jbc.M112.381897","article-title":"Structural study reveals that Ser-354 determines substrate specificity on human histidine decarboxylase","volume":"287","author":"Komori","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"Pt B","key":"10.1016\/j.pneurobio.2016.07.002_bib1485","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.neuropharm.2013.05.024","article-title":"Addiction as a stress surfeit disorder","volume":"76","author":"Koob","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1490","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0024-3205(92)90484-7","article-title":"L-dopa administration enhances exocytotic dopamine release in vivo in the rat striatum","volume":"51","author":"Koshimura","year":"1992","journal-title":"Life Sci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1495","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00726-005-0162-4","article-title":"Peculiarities of L: \u2212DOPA treatment of parkinson's disease","volume":"28","author":"Kostrzewa","year":"2005","journal-title":"Amino Acids"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0149-7634(94)00019-W","article-title":"Dopamine receptor supersensitivity","volume":"19","author":"Kostrzewa","year":"1995","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1505","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00001756-200301200-00014","article-title":"Nucleus-specific alteration of raphe neurons in human neurodegenerative disorders","volume":"14","author":"Kovacs","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1510","doi-asserted-by":"crossref","first-page":"6807","DOI":"10.1523\/JNEUROSCI.17-17-06807.1997","article-title":"The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease","volume":"17","author":"Kreiss","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1515","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neulet.2011.03.050","article-title":"High levels of histidine decarboxylase in the striatum of mice and rats","volume":"495","author":"Krusong","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1520","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1523\/JNEUROSCI.18-18-07111.1998","article-title":"Dopamine inactivates tryptophan hydroxylase and forms a redox-cycling quinoprotein: possible endogenous toxin to serotonin neurons","volume":"18","author":"Kuhn","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1525","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0169-328X(99)00238-7","article-title":"L-DOPA-quinone inactivates tryptophan hydroxylase and converts the enzyme to a redox-cycling quinoprotein","volume":"73","author":"Kuhn","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1530","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1212\/WNL.50.5_Suppl_5.S3","article-title":"COMT inhibition: a new treatment strategy for Parkinson's disease","volume":"50","author":"Kurth","year":"1998","journal-title":"Neurology"},{"issue":"Supplementum","key":"10.1016\/j.pneurobio.2016.07.002_bib1535","first-page":"49","article-title":"MPTP-induced parkinsonism in human and non-human primates?clinical and experimental aspects","volume":"100","author":"Langston","year":"1984","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1540","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.1523\/JNEUROSCI.0576-11.2011","article-title":"Dopamine transport by the serotonin transporter: a mechanistically distinct mode of substrate translocation","volume":"31","author":"Larsen","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1545","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1152\/physrev.1991.71.1.155","article-title":"Mesocorticolimbic dopaminergic network: functional and regulatory roles","volume":"71","author":"Le Moal","year":"1991","journal-title":"Physiol. Rev."},{"issue":"Suppl 1","key":"10.1016\/j.pneurobio.2016.07.002_bib1550","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S1353-8020(11)70017-7","article-title":"Recent advances in CSF biomarkers for Parkinson's disease","volume":"18","author":"LeWitt","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1555","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11064-007-9442-6","article-title":"The role of 3-O-methyldopa in the side effects of L-dopa","volume":"33","author":"Lee","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1560","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mds.26120","article-title":"Four pioneers of L-dopa treatment: arvid carlsson oleh hornykiewicz, george cotzias, and melvin yahr","volume":"30","author":"Lees","year":"2015","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1565","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/BF00247354","article-title":"Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation","volume":"74","author":"Lindefors","year":"1989","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1570","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuroscience.2015.09.018","article-title":"Alterations in primary motor cortex neurotransmission and gene expression in hemi-parkinsonian rats with drug-induced dyskinesia","volume":"310","author":"Lindenbach","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1575","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/bph.12894","article-title":"Side effect profile of 5-HT treatments for Parkinson's disease and L-DOPA-induced dyskinesia in rats","volume":"172","author":"Lindenbach","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1580","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1471-4159.2009.06556.x","article-title":"L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia","volume":"112","author":"Lindgren","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1585","doi-asserted-by":"crossref","first-page":"e76651","DOI":"10.1371\/journal.pone.0076651","article-title":"Comparative efficacy and acceptability of antidepressants in Parkinson's disease: a network meta-analysis","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1590","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1126\/science.170.3963.1212","article-title":"Parkinson's disease: activity of L-dopa decarboxylase in discrete brain regions","volume":"170","author":"Lloyd","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1595","first-page":"453","article-title":"The neurochemistry of Parkinson's disease: effect of L-dopa therapy","volume":"195","author":"Lloyd","year":"1975","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1600","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0306-4522(00)00588-1","article-title":"Mechanisms of the effects of exogenous levodopa on the dopamine-denervated striatum","volume":"103","author":"Lopez","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1605","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1371\/journal.pbio.0060236","article-title":"L-DOPA is an endogenous ligand for OA1","volume":"6","author":"Lopez","year":"2008","journal-title":"PLoS Biol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1610","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1460-9568.2002.02150.x","article-title":"5-HT4 receptors exert a frequency-related facilitatory control on dorsal raphe nucleus 5-HT neuronal activity","volume":"16","author":"Lucas","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1615","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.parkreldis.2008.10.001","article-title":"Correlation between changes in CSF dopamine turnover and development of dyskinesia in Parkinson's disease","volume":"15","author":"Lunardi","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1620","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1471-4159.2008.05848.x","article-title":"Chronic intermittent L-DOPA treatment induces changes in dopamine release","volume":"108","author":"Lundblad","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1625","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neuroscience.2009.12.006","article-title":"Endogenous nociceptin\/orphanin FQ (N\/OFQ) contributes to haloperidol-induced changes of nigral amino acid transmission and parkinsonism: a combined microdialysis and behavioral study in naive and nociceptin\/orphanin FQ receptor knockout mice","volume":"166","author":"Mabrouk","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1630","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1432-1033.1997.00265.x","article-title":"Tubulin post-translational modifications?enzymes and their mechanisms of action","volume":"244","author":"MacRae","year":"1997","journal-title":"Eur. J. Biochem.\/FEBS"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1635","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0006-8993(98)01248-7","article-title":"Loss of regulation by presynaptic dopamine D2 receptors of exogenous L-DOPA-derived dopamine release in the dopaminergic denervated striatum","volume":"817","author":"Maeda","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1640","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0047-6374(83)90100-8","article-title":"The locus coeruleus and its possible role in ageing and degenerative disease of the human central nervous system","volume":"23","author":"Mann","year":"1983","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1645","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/mds.1149","article-title":"Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naive MPTP-lesioned common marmosets (Callithrix jacchus)","volume":"16","author":"Maratos","year":"2001","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1650","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/syn.10291","article-title":"Bilateral subthalamic nucleus lesion reverses L-dopa-induced motor fluctuations and facilitates dyskinetic movements in hemiparkinsonian rats","volume":"51","author":"Marin","year":"2004","journal-title":"Synapse (New York, N.Y.)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1655","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00213-008-1452-9","article-title":"Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned rats","volume":"204","author":"Marin","year":"2009","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1660","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.expneurol.2013.10.006","article-title":"Subthalamic 6-OHDA-induced lesion attenuates levodopa-induced dyskinesias in the rat model of Parkinson's disease","volume":"250","author":"Marin","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1665","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0306-4522(02)00050-7","article-title":"Nociceptin\/orphanin FQ receptors modulate glutamate extracellular levels in the substantia nigra pars reticulata. A microdialysis study in the awake freely moving rat","volume":"112","author":"Marti","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1670","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1523\/JNEUROSCI.4346-06.2007","article-title":"The nociceptin\/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathway","volume":"27","author":"Marti","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1675","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1471-4159.2008.05735.x","article-title":"The novel nociceptin\/orphanin FQ receptor antagonist Trap-101 alleviates experimental parkinsonism through inhibition of the nigro-thalamic pathway: positive interaction with L-DOPA","volume":"107","author":"Marti","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1680","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1460-9568.2012.08002.x","article-title":"Subpopulations of cholinergic: gABAergic and glutamatergic neurons in the pedunculopontine nucleus contain calcium-binding proteins and are heterogeneously distributed","volume":"35","author":"Martinez-Gonzalez","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1685","first-page":"1451","article-title":"Divergent motor projections from the pedunculopontine nucleus are differentially regulated in Parkinsonism","volume":"219","author":"Martinez-Gonzalez","year":"2014","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1690","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF01250960","article-title":"The mechanism of perturbation in monoamine metabolism by L-dopa therapy: in vivo and in vitro studies","volume":"90","author":"Maruyama","year":"1992","journal-title":"J. Neural Transm. Gen. Sec."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1695","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1097\/00001756-200011090-00021","article-title":"Expression of a system L neutral amino acid transporter at the blood-brain barrier","volume":"11","author":"Matsuo","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1700","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/ane.12314","article-title":"Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson\u2019s disease","volume":"131","author":"Mazzucchi","year":"2015","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1705","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2016.01.013","article-title":"The novel 5-HT receptor agonist, NLX-112 reduces L-DOPA-induced abnormal involuntary movements in rat: a chronic administration study with microdialysis measurements","author":"McCreary","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1710","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1046\/j.1471-4159.1997.69020791.x","article-title":"Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis","volume":"69","author":"McQuade","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1715","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1471-4159.2003.01665.x","article-title":"High-frequency stimulation of the subthalamic nucleus enhances striatal dopamine release and metabolism in rats","volume":"85","author":"Meissner","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1720","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.nbd.2006.01.009","article-title":"Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine","volume":"22","author":"Meissner","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1725","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1471-4159.2007.04456.x","article-title":"Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease","volume":"101","author":"Mela","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1730","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.neuropharm.2009.08.017","article-title":"The selective D(3) receptor antagonist S33084, improves parkinsonian-like motor dysfunction but does not affect L-DOPA-induced dyskinesia in 6-hydroxydopamine hemi-lesioned rats","volume":"58","author":"Mela","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1735","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.nbd.2011.09.015","article-title":"In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels","volume":"45","author":"Mela","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1740","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/283772a0","article-title":"Serotonergic neurones are not involved in action of L-dopa in Parkinson's disease","volume":"283","author":"Melamed","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1745","first-page":"545","article-title":"Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapy","volume":"69","author":"Melamed","year":"1996","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1750","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1002\/ana.410440722","article-title":"Levodopa toxicity and apoptosis","volume":"44","author":"Melamed","year":"1998","journal-title":"Ann. Neurol."},{"issue":"Supplementum","key":"10.1016\/j.pneurobio.2016.07.002_bib1755","first-page":"57","article-title":"Does treatment with dopamine agonists affect utilization of exogenous levodopa in the parkinsonian striatum?","volume":"45","author":"Melamed","year":"1995","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1760","first-page":"39","article-title":"Plasma clozapine levels and the treatment of L-DOPA-induced psychosis in Parkinson's disease: a high potency effect of clozapine","volume":"12","author":"Meltzer","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1765","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/npp.2009.176","article-title":"Pimavanserin a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis","volume":"35","author":"Meltzer","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1770","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.tips.2005.05.002","article-title":"The \u2018magic' of L-dopa: why is it the gold standard Parkinson's disease therapy?","volume":"26","author":"Mercuri","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1775","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1476-5381.1990.tb15792.x","article-title":"Responses of rat substantia nigra compacta neurones to L-DOPA","volume":"100","author":"Mercuri","year":"1990","journal-title":"Br. J. Pharmacol."},{"issue":"Suppl 2","key":"10.1016\/j.pneurobio.2016.07.002_bib1780","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.parkreldis.2008.04.012","article-title":"Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol","volume":"14","author":"Meredith","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1785","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/0028-3908(95)00148-Y","article-title":"Transport of histamine by vesicular monoamine transporter-2","volume":"34","author":"Merickel","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1790","doi-asserted-by":"crossref","first-page":"e24679","DOI":"10.1371\/journal.pone.0024679","article-title":"The locus coeruleus is directly implicated in L-DOPA-induced dyskinesia in parkinsonian rats: an electrophysiological and behavioural study","volume":"6","author":"Miguelez","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1795","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neuropharm.2012.11.016","article-title":"L-DOPA modifies the antidepressant-like effects of reboxetine and fluoxetine in rats","volume":"67","author":"Miguelez","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1800","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fncir.2014.00021","article-title":"Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease","volume":"8","author":"Miguelez","year":"2014","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1805","doi-asserted-by":"crossref","DOI":"10.1111\/bph.13447","article-title":"The acute and long-term L-DOPA effects are independent from changes in the activity of dorsal raphe serotonergic neurons in 6-OHDA lesioned rats","author":"Miguelez","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1810","doi-asserted-by":"crossref","DOI":"10.1016\/j.euroneuro.2016.05.004","article-title":"L-DOPA elicits non-vesicular releases of serotonin and dopamine in hemiparkinsonian rats in vivo","author":"Miguelez","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1815","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/026988110001400202","article-title":"Reciprocal autoreceptor and heteroreceptor control of serotonergic dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents","volume":"14","author":"Millan","year":"2000","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1820","first-page":"1206","article-title":"S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine","volume":"295","author":"Millan","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1825","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1098-2396(200002)35:2<79::AID-SYN1>3.0.CO;2-X","volume":"35","author":"Millan","year":"2000","journal-title":"Synapse (New York, N.Y.)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1830","first-page":"565","article-title":"S33005, a novel ligand at both serotonin and norepinephrine transporters: i. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine","volume":"298","author":"Millan","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1835","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1124\/jpet.102.039867","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I: A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes","volume":"303","author":"Millan","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1840","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1124\/jpet.103.062398","article-title":"S32504, a novel naphtoxazine agonist at dopamine D3\/D2 receptors: i. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole","volume":"309","author":"Millan","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1845","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.euroneuro.2015.01.016","article-title":"Learning from the past and looking to the future: emerging perspectives for improving the treatment of psychiatric disorders","volume":"25","author":"Millan","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1850","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pharmthera.2005.11.006","article-title":"Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application","volume":"110","author":"Millan","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1855","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pharmthera.2010.06.002","article-title":"From the cell to the clinic: a comparative review of the partial D(2)\/D(3)receptor agonist and alpha2-adrenoceptor antagonist piribedil, in the treatment of Parkinson's disease","volume":"128","author":"Millan","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1860","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1046\/j.1471-4159.1999.721516.x","article-title":"Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous L-DOPA: studies in intact and 6-hydroxydopamine-treated rats","volume":"72","author":"Miller","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1865","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0169-328X(92)90104-J","article-title":"Effect of the selective lesion of serotoninergic neurons on the regional distribution of 5-HT1A receptor mRNA in the rat brain","volume":"14","author":"Miquel","year":"1992","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1870","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-3806(94)90099-X","article-title":"Postnatal development and localization of 5-HT1A receptor mRNA in rat forebrain and cerebellum","volume":"80","author":"Miquel","year":"1994","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1875","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0165-6147(93)90082-U","article-title":"Is L-dopa an endogenous neurotransmitter?","volume":"14","author":"Misu","year":"1993","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1880","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0304-3940(86)90079-0","article-title":"Biphasic actions of L-DOPA on the release of endogenous dopamine via presynaptic receptors in rat striatal slices","volume":"72","author":"Misu","year":"1986","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1885","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0006-8993(90)91725-V","article-title":"Nicotine releases stereoselectively and Ca2(+)-dependently endogenous 3,4-dihydroxyphenylalanine from rat striatal slices","volume":"520","author":"Misu","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1890","first-page":"427","article-title":"Neurotransmitter-like actions of L-DOPA","volume":"32","author":"Misu","year":"1995","journal-title":"Adv. Pharmacol. (San Diego, Calif.)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1895","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0301-0082(96)00025-1","article-title":"Neurobiology of L-DOPAergic systems","volume":"49","author":"Misu","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1900","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0031-9384(91)90245-J","article-title":"Active transport pumps of HVA and DOPAC in dopaminergic nerve terminals","volume":"49","author":"Miyamoto","year":"1991","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1905","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0006-8993(93)91787-S","article-title":"Dopamine formation from L-dopa administered exogenously is independent of dopaminergic neuronal activity: studies with in vivo microdialysis","volume":"611","author":"Mizoguchi","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1910","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1097\/00004714-198712001-00002","article-title":"Serotonergic neuronal systems: what their anatomic organization tells us about function","volume":"7","author":"Molliver","year":"1987","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1915","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/syn.890040203","article-title":"Identification of L-dopa-dopamine and L-dopa cell bodies in the rat mesencephalic dopaminergic cell systems","volume":"4","author":"Mons","year":"1989","journal-title":"Synapse (New York, N.Y.)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1920","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.chembiol.2011.08.008","article-title":"Bacterial and eukaryotic phenylalanyl-tRNA synthetases catalyze misaminoacylation of tRNA(Phe) with 3,4-dihydroxy-L-phenylalanine","volume":"18","author":"Moor","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1925","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.neuropharm.2015.08.002","article-title":"Contribution of brain serotonin subtype 1 B receptors in levodopa-induced motor complications","volume":"99","author":"Morin","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1930","doi-asserted-by":"crossref","first-page":"9304","DOI":"10.1523\/JNEUROSCI.0519-06.2006","article-title":"Alpha-synuclein overexpression increases cytosolic catecholamine concentration","volume":"26","author":"Mosharov","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1935","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neuron.2009.01.033","article-title":"Interplay between cytosolic dopamine calcium, and alpha-synuclein causes selective death of substantia nigra neurons","volume":"62","author":"Mosharov","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1940","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mds.26103","article-title":"Presynaptic effects of levodopa and their possible role in dyskinesia","volume":"30","author":"Mosharov","year":"2015","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1945","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0306-4522(96)00452-6","article-title":"Quantitative and morphometric data indicate precise cellular interactions between serotonin terminals and postsynaptic targets in rat substantia nigra","volume":"76","author":"Moukhles","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1950","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s00702-014-1213-3","article-title":"Fewer fluctuations, higher maximum concentration and better motor response of levodopa with catechol-O-methyltransferase inhibition","volume":"121","author":"Muhlack","year":"2014","journal-title":"J. Neural Transm. (Vienna, Austria: 1996)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1955","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1093\/brain\/awn235","article-title":"Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia","volume":"131","author":"Munoz","year":"2008","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1960","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.expneurol.2009.05.033","article-title":"Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1 B receptor agonists in the rat Parkinson model","volume":"219","author":"Munoz","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1965","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0006-8993(95)01104-8","article-title":"Aromatic L-amino acid decarboxylase immunoreactive cells in the rat striatum: a possible site for the conversion of exogenous L-DOPA to dopamine","volume":"704","author":"Mura","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1970","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ana.410430504","article-title":"Chronic levodopa is not toxic for remaining dopamine neurons but instead promotes their recovery, in rats with moderate nigrostriatal lesions","volume":"43","author":"Murer","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1975","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1111\/j.1471-4159.2010.06723.x","article-title":"Distribution of catechol-O-methyltransferase (COMT) proteins and enzymatic activities in wild-type and soluble COMT deficient mice","volume":"113","author":"Myohanen","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1980","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1124\/jpet.102.042267","article-title":"Levodopa is toxic to dopamine neurons in an in vitro but not an in vivo model of oxidative stress","volume":"304","author":"Mytilineou","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1985","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1471-4159.2011.07598.x","article-title":"Serotonergic modulation of receptor occupancy in rats treated with L-DOPA after unilateral 6-OHDA lesioning","volume":"120","author":"Nahimi","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1990","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0014-2999(92)90465-G","article-title":"Transmitter-like 3,4-dihydroxyphenylalanine is tonically released by nicotine in striata of conscious rats","volume":"222","author":"Nakamura","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib1995","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0304-3940(94)90229-1","article-title":"Non-effective dose of exogenously applied L-dopa itself stereoselectively potentiates postsynaptic D2 receptor-mediated locomotor activities of conscious rats","volume":"170","author":"Nakamura","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2000","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/096368970000900502","article-title":"The localization and functional contribution of striatal aromatic L-amino acid decarboxylase to L-3, 4-dihydroxyphenylalanine decarboxylation in rodent parkinsonian models","volume":"9","author":"Nakamura","year":"2000","journal-title":"Cell Transplant."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2005","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1523\/JNEUROSCI.0021-08.2008","article-title":"Reward-dependent modulation of neuronal activity in the primate dorsal raphe nucleus","volume":"28","author":"Nakamura","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2010","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0006-8993(89)90250-3","article-title":"Effect of exogenous L-dopa on behavior in the rat: an in vivo voltammetric study","volume":"490","author":"Nakazato","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1471-4159.1992.tb09286.x","article-title":"Decarboxylation of exogenous L-3, 4-dihydroxyphenylalanine in rat striatum as studied by in vivo voltammetry","volume":"58","author":"Nakazato","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2020","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0006-8993(02)02238-2","article-title":"Behavioral activity and stereotypy in rats induced by L-DOPA metabolites: a possible role in the adverse effects of chronic L-DOPA treatment of Parkinson's disease","volume":"930","author":"Nakazato","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0168-0102(02)00027-5","article-title":"Functional significance of the cortico-subthalamo-pallidal \u2018hyperdirect' pathway","volume":"43","author":"Nambu","year":"2002","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2030","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.conb.2008.11.001","article-title":"Seven problems on the basal ganglia","volume":"18","author":"Nambu","year":"2008","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2035","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1093\/brain\/awr233","article-title":"Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease","volume":"134","author":"Nandhagopal","year":"2011","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00213-010-2029-y","article-title":"Presynaptic control of serotonin on striatal dopamine function","volume":"213","author":"Navailles","year":"2011","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2045","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12035-011-8230-0","article-title":"Contribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson's disease","volume":"45","author":"Navailles","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2050","first-page":"323686","article-title":"Imbalanced dopaminergic transmission mediated by serotonergic neurons in L-DOPA-Induced dyskinesia","volume":"2012","author":"Navailles","year":"2012","journal-title":"Parkinson's Dis."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2055","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1523\/JNEUROSCI.5031-09.2010","article-title":"High-frequency stimulation of the subthalamic nucleus and L-3, 4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson's disease","volume":"30","author":"Navailles","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2060","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.nbd.2010.11.007","article-title":"Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease","volume":"41","author":"Navailles","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2065","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.nbd.2010.01.012","article-title":"Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease","volume":"38","author":"Navailles","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2070","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.nbd.2010.11.007","article-title":"Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease","volume":"41","author":"Navailles","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2075","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2174\/1871524911106040305","article-title":"L-DOPA and serotonergic neurons: functional implication and therapeutic perspectives in Parkinson's disease","volume":"11","author":"Navailles","year":"2011","journal-title":"Central Nervous Syst. Agents Med. Chem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2080","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1021\/cn400046e","article-title":"Multisite intracerebral microdialysis to study the mechanism of L-DOPA induced dopamine and serotonin release in the parkinsonian brain","volume":"4","author":"Navailles","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2085","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/cns.12252","article-title":"Predicting dopaminergic effects of L-DOPA in the treatment for Parkinson's disease","volume":"20","author":"Navailles","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2090","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/cns.12275","article-title":"Noradrenergic terminals regulate L-DOPA-derived dopamine extracellular levels in a region-dependent manner in Parkinsonian rats","volume":"20","author":"Navailles","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2095","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/cns.12436","article-title":"The 5-HT4 agonist prucalopride stimulates L-DOPA-Induced dopamine release in restricted brain regions of the hemiparkinsonian rat In vivo","volume":"21","author":"Navailles","year":"2015","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2100","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1471-4159.2011.07292.x","article-title":"Dopamine release from serotonergic nerve fibers is reduced in L-DOPA-induced dyskinesia","volume":"118","author":"Nevalainen","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neuroscience.2013.12.029","article-title":"Serotonergic nerve fibers in L-DOPA-derived dopamine release and dyskinesia","volume":"260","author":"Nevalainen","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2110","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1124\/jpet.102.039875","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II: Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)\/alpha(2)-adrenoceptor","volume":"303","author":"Newman-Tancredi","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1126\/science.170.3953.76","article-title":"L-Dopa-induced release of cerebral monoamines","volume":"170","author":"Ng","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2120","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1126\/science.172.3982.487","article-title":"Dopamine: stimulation-induced release from central neurons","volume":"172","author":"Ng","year":"1971","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2125","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1212\/WNL.22.7.688","article-title":"L-dopa in Parkinsonism: a possible mechanism of action","volume":"22","author":"Ng","year":"1972","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2130","first-page":"316","article-title":"Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates","volume":"183","author":"Ng","year":"1972","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2135","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.0953-816x.2001.01644.x","article-title":"Effect of microiontophoretic application of dopamine on subthalamic nucleus neuronal activity in normal rats and in rats with unilateral lesion of the nigrostriatal pathway","volume":"14","author":"Ni","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0301-0082(02)00011-4","article-title":"Dopamine and the regulation of cognition and attention","volume":"67","author":"Nieoullon","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2145","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1016\/j.celrep.2016.02.046","article-title":"Alpha-Tubulin tyrosination and CLIP-170 phosphorylation regulate the initiation of dynein-Driven transport in neurons","volume":"14","author":"Nirschl","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2150","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/syn.890060113","article-title":"In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis","volume":"6","author":"Nomikos","year":"1990","journal-title":"Synapse (New York, N.Y.)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2155","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1055\/s-2007-979504","article-title":"Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine","volume":"30","author":"Normann","year":"1997","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2160","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S1471-1931(00)00028-8","article-title":"Pathophysiology of the basal ganglia in Parkinson's disease","volume":"23","author":"Obeso","year":"2000","journal-title":"Trends Neurosci."},{"issue":"Suppl 2","key":"10.1016\/j.pneurobio.2016.07.002_bib2165","first-page":"S30","article-title":"The basal ganglia in Parkinson's disease: current concepts and unexplained observations","volume":"64","author":"Obeso","year":"2008","journal-title":"Ann. Neurol."},{"issue":"Suppl 3","key":"10.1016\/j.pneurobio.2016.07.002_bib2170","doi-asserted-by":"crossref","first-page":"S548","DOI":"10.1002\/mds.22062","article-title":"Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease","volume":"23","author":"Obeso","year":"2008","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2175","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0306-4522(00)00250-5","article-title":"Systemic administration of adenosine A(2A) receptor antagonist reverses increased GABA release in the globus pallidus of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study","volume":"100","author":"Ochi","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2180","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neuroscience.2004.04.050","article-title":"Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease","volume":"127","author":"Ochi","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2185","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1023\/A:1007530720544","article-title":"Bromocriptine markedly suppresses levodopa-induced abnormal increase of dopamine turnover in the parkinsonian striatum","volume":"25","author":"Ogawa","year":"2000","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2190","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/oxfordjournals.jbchem.a003001","article-title":"Changing the amino acid specificity of yeast tyrosyl-tRNA synthetase by genetic engineering","volume":"130","author":"Ohno","year":"2001","journal-title":"J. Biochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2195","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pneurobio.2015.09.005","article-title":"New insight into the therapeutic role of the serotonergic system in Parkinson's disease","volume":"134","author":"Ohno","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2200","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ana.410290516","article-title":"Temporal relationships between plasma and cerebrospinal fluid pharmacokinetics of levodopa and clinical effect in Parkinson's disease","volume":"29","author":"Olanow","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2205","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1212\/WNL.0b013e3181a1d44c","article-title":"The scientific and clinical basis for the treatment of Parkinson disease (2009)","volume":"72","author":"Olanow","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2210","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/mds.26119","article-title":"Levodopa: effect on cell death and the natural history of Parkinson's disease","volume":"30","author":"Olanow","year":"2015","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2215","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/srep01447","article-title":"The real catecholamine content of secretory vesicles in the CNS revealed by electrochemical cytometry","volume":"3","author":"Omiatek","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2220","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1248\/bpb.b110714","article-title":"Effects of 3-O-methyldopa L-3,4-dihydroxyphenylalanine metabolite, on locomotor activity and dopamine turnover in rats","volume":"35","author":"Onzawa","year":"2012","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2225","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/0014-4886(92)90203-3","article-title":"Simultaneous microdialysis in striatum and substantia nigra suggests that the nigra is a major site of action of L-dihydroxyphenylalanine in the hemiparkinsonian rat","volume":"115","author":"Orosz","year":"1992","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2230","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.neuropharm.2011.05.021","article-title":"Role of the primary motor cortex in L-DOPA-induced dyskinesia and its modulation by 5-HT1A receptor stimulation","volume":"61","author":"Ostock","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2235","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbr.2014.05.009","article-title":"Effects of noradrenergic denervation by anti-DBH-saporin on behavioral responsivity to L-DOPA in the hemi-parkinsonian rat","volume":"270","author":"Ostock","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2240","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuropharm.2015.03.008","article-title":"Modulation of L-DOPA's antiparkinsonian and dyskinetic effects by alpha2-noradrenergic receptors within the locus coeruleus","volume":"95","author":"Ostock","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2245","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1111\/j.1742-4658.2005.04735.x","article-title":"Translational incorporation of L-3, 4-dihydroxyphenylalanine into proteins","volume":"272","author":"Ozawa","year":"2005","journal-title":"FEBS J."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2250","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/138161212799040574","article-title":"Current opinions and perspectives on the role of immune system in the pathogenesis of Parkinson's disease","volume":"18","author":"Panaro","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2255","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/mds.26326","article-title":"Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity","volume":"30","author":"Paolone","year":"2015","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2260","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/mds.25218","article-title":"Levodopa infusion does not decrease the onset of abnormal involuntary movements in parkinsonian rats","volume":"28","author":"Papathanou","year":"2013","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2265","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00213-009-1505-8","article-title":"The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism","volume":"204","author":"Paquette","year":"2009","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2270","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1111\/j.1460-9568.2012.08243.x","article-title":"Anti-dyskinetic mechanisms of amantadine and dextromethorphan in the 6-OHDA rat model of Parkinson's disease: role of NMDA vs. 5-HT1A receptors","volume":"36","author":"Paquette","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2275","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s10545-012-9473-2","article-title":"In vivo catecholaminergic metabolism in the medial prefrontal cortex of ENU2 mice: an investigation of the cortical dopamine deficit in phenylketonuria","volume":"35","author":"Pascucci","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2280","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1073\/pnas.1507610113","article-title":"Regional specialization within the human striatum for diverse psychological functions","volume":"113","author":"Pauli","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2285","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.neuroimage.2011.09.034","article-title":"[(1)(8)F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability: a combined [(1)(8)F]FDOPA and [(1)(1)C]DASB PET study in Parkinson's disease","volume":"59","author":"Pavese","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2290","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2007.08.024","article-title":"Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration","volume":"576","author":"Perez","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2295","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1083\/jcb.200512058","article-title":"Tubulin tyrosination is a major factor affecting the recruitment of CAP-Gly proteins at microtubule plus ends","volume":"174","author":"Peris","year":"2006","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2300","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1523\/JNEUROSCI.15-09-06179.1995","article-title":"Differential expression of two vesicular monoamine transporters","volume":"15","author":"Peter","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2305","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0024-3205(95)00051-7","article-title":"Ischemia increases tissue and decreases extracellular levels of acid dopamine metabolites in the rat striatum: further evidence for active transport of metabolites","volume":"56","author":"Phebus","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2310","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.neuro.2005.02.002","article-title":"Pathological synaptic plasticity in the striatum: implications for Parkinson's disease","volume":"26","author":"Picconi","year":"2005","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2315","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/ana.22231","article-title":"L-3,4-dihydroxyphenylalanine-induced sprouting of serotonin axon terminals: a useful biomarker for dyskinesias?","volume":"68","author":"Picconi","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2320","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/978-3-7091-0932-8_24","article-title":"Synaptic dysfunction in Parkinson's disease","volume":"970","author":"Picconi","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2325","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1388-2457(01)00694-0","article-title":"Deep brain stimulation of both subthalamic nucleus and internal globus pallidus restores intracortical inhibition in Parkinson's disease paralleling apomorphine effects: a paired magnetic stimulation study","volume":"113","author":"Pierantozzi","year":"2002","journal-title":"Clinical Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2330","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1600-0404.1998.tb05955.x","article-title":"Low dosage clozapine effects on L-dopa induced dyskinesias in parkinsonian patients","volume":"97","author":"Pierelli","year":"1998","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2335","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0306-4522(91)90080-8","article-title":"Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey","volume":"44","author":"Pifl","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2340","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.nbd.2010.05.028","article-title":"Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study","volume":"40","author":"Politis","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2345","doi-asserted-by":"crossref","first-page":"128ra141","DOI":"10.1126\/scitranslmed.3003391","article-title":"Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts","volume":"4","author":"Politis","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2350","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1172\/JCI71640","article-title":"Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients","volume":"124","author":"Politis","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2355","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1523\/JNEUROSCI.12-02-00440.1992","article-title":"Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding","volume":"12","author":"Pompeiano","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2360","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1172\/JCI59426","article-title":"PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking","volume":"122","author":"Porras","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2365","doi-asserted-by":"crossref","first-page":"a009308","DOI":"10.1101\/cshperspect.a009308","article-title":"Modeling parkinson's disease in primates: the MPTP model","volume":"2","author":"Porras","year":"2012","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2370","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1038\/srep03730","article-title":"L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum","volume":"4","author":"Porras","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2375","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/brain\/awn322","article-title":"Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients","volume":"132","author":"Prescott","year":"2009","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2380","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.brainres.2005.08.049","article-title":"Functional role of alpha1-adrenoceptors in the locus coeruleus: a microdialysis study","volume":"1061","author":"Pudovkina","year":"2005","journal-title":"Brain Res."},{"issue":"Suppl 4","key":"10.1016\/j.pneurobio.2016.07.002_bib2385","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S1353-8020(09)70846-6","article-title":"Hallucinations and psychosis in Parkinson's disease","volume":"15","author":"Rabey","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-0186(91)90029-D","article-title":"Autoradiography of serotonin receptor subtypes in the central nervous system","volume":"18","author":"Radja","year":"1991","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2395","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0021-5198(19)52616-6","article-title":"Effect of pyridoxal phosphate deficiency on aromatic L-amino acid decarboxylase activity with L-DOPA and L-5-hydroxytryptophan as substrates in rats","volume":"32","author":"Rahman","year":"1982","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2400","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/mds.10176","article-title":"The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia","volume":"17","author":"Reddy","year":"2002","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2405","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fnint.2012.00021","article-title":"Mathematical insights into the effects of levodopa","volume":"6","author":"Reed","year":"2012","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2410","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A","article-title":"Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1 B serotonin receptors in adult rat brain","volume":"417","author":"Riad","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2415","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.bcp.2013.08.005","article-title":"Basal ganglia serotonin 1 B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia","volume":"86","author":"Riahi","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2420","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/WNF.0b013e3181d99d6f","article-title":"Replacing a dopamine agonist by the COMT-inhibitor tolcapone as an adjunct to L-dopa in the treatment of Parkinson's disease: a randomized multicenter, open-label, parallel-group study","volume":"33","author":"Ries","year":"2010","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2425","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1523\/JNEUROSCI.09-09-03326.1989","article-title":"Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms","volume":"9","author":"Robertson","year":"1989","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2430","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0006-8993(91)91545-C","article-title":"Further investigations into the pathophysiology of MPTP-induced parkinsonism in the primate: an intracerebral microdialysis study of gamma-aminobutyric acid in the lateral segment of the globus pallidus","volume":"563","author":"Robertson","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2435","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.freeradbiomed.2004.08.009","article-title":"Biosynthesis and turnover of DOPA-containing proteins by human cells","volume":"37","author":"Rodgers","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2440","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1471-4159.2006.03941.x","article-title":"Evidence for L-dopa incorporation into cell proteins in patients treated with levodopa","volume":"98","author":"Rodgers","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2445","first-page":"277","article-title":"Regional effects of L-dihydroxyphenylalanine (L-dopa) on norepinephrine metabolism in rat brain","volume":"180","author":"Romero","year":"1972","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2450","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/ana.22097","article-title":"Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia","volume":"68","author":"Rylander","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2455","series-title":"The Tenth International Catecholamine Symposium","article-title":"Role of the organic cation transporter (OCT-3) and monoamine oxidase types a and B in the metabolism of dopamine derived from L-DOPA in rat striatum depleted of dopaminergic and serotonergic afferent inputs","author":"Sader-Mazbar","year":"2012"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2460","doi-asserted-by":"crossref","first-page":"30470","DOI":"10.1074\/jbc.270.51.30470","article-title":"Purification, characterization, and molecular cloning of a novel rat liver Dopa\/tyrosine sulfotransferase","volume":"270","author":"Sakakibara","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2465","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00427655","article-title":"Experimental influences on catalepsy","volume":"69","author":"Sanberg","year":"1980","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2470","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/284472a0","article-title":"Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors","volume":"284","author":"Sanberg","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2475","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00173540","article-title":"Biotransformation of L-dopa in striatum and substantia nigra of rats with a unilateral: nigrostriatal lesion: a microdialysis study","volume":"346","author":"Sarre","year":"1992","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2480","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00180005","article-title":"Biotransformation of locally applied L-dopa in the corpus striatum of the hemi-parkinsonian rat studied with microdialysis","volume":"350","author":"Sarre","year":"1994","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2485","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/BF01294722","article-title":"Biotransformation of locally applied precursors of dopamine: serotonin and noradrenaline in striatum and hippocampus: a microdialysis study","volume":"104","author":"Sarre","year":"1997","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2490","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/mds.10464","article-title":"Fipamezole (JP-1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease","volume":"18","author":"Savola","year":"2003","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2495","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-8993(83)90993-9","article-title":"Reduction of cortical dopamine noradrenaline, serotonin and their metabolites in Parkinson's disease","volume":"275","author":"Scatton","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2500","doi-asserted-by":"crossref","first-page":"e61392","DOI":"10.1371\/journal.pone.0061392","article-title":"Catechol-O-methyltransferase (COMT) protein expression and activity after dopaminergic and noradrenergic lesions of the rat brain","volume":"8","author":"Schendzielorz","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2505","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/01.WNF.0000229013.95927.C7","article-title":"Challenging the serotonergic system in Parkinson disease patients: effects on cognition mood, and motor performance","volume":"29","author":"Scholtissen","year":"2006","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2510","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00702-005-0368-3","article-title":"Serotonergic mechanisms in Parkinson's disease: opposing results from preclinical and clinical data","volume":"113","author":"Scholtissen","year":"2006","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2515","first-page":"229","article-title":"Brain dopamine receptors","volume":"32","author":"Seeman","year":"1980","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2520","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/0304-3940(86)90580-X","article-title":"gamma-Aminobutyric acid release in the globus pallidus in vivo after a 6-hydroxydopamine lesion in the substantia nigra of the rat","volume":"70","author":"Segovia","year":"1986","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2525","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1471-4159.1989.tb07319.x","article-title":"In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: changes in relation to 5-hydroxytryptaminergic neuronal activity","volume":"53","author":"Sharp","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2530","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1620\/tjem.199.149","article-title":"Effects of benserazide on L-DOPA-derived extracellular dopamine levels and aromatic L-amino acid decarboxylase activity in the striatum of 6-hydroxydopamine-lesioned rats","volume":"199","author":"Shen","year":"2003","journal-title":"Tohoku. J. Exp. Med."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2535","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.neuropharm.2006.01.001","article-title":"L-3, 4-dihydroxyphenylalanine-induced c-Fos expression in the CNS under inhibition of central aromatic L-amino acid decarboxylase","volume":"50","author":"Shimamura","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2540","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.expneurol.2014.04.011","article-title":"Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease","volume":"257","author":"Shin","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2545","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neulet.2010.03.060","article-title":"High frequency stimulation of the subthalamic nucleus evokes striatal dopamine release in a large animal model of human DBS neurosurgery","volume":"475","author":"Shon","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2550","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410360305","article-title":"Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia","volume":"36","author":"Sian","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2555","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s00702-006-0493-7","article-title":"L-DOPA inhibits depolarization-induced [3H]GABA release in the dopamine-denervated globus pallidus of the rat: the effect is dopamine independent and mediated by D2-like receptors","volume":"113","author":"Silva","year":"2006","journal-title":"J. Neural Transm. (Vienna, Austria: 1996)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2560","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.expneurol.2004.03.022","article-title":"Selective blockade of D(3) dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate","volume":"188","author":"Silverdale","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2565","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2377-10-49","article-title":"Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Skapinakis","year":"2010","journal-title":"BMC Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2570","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.freeradbiomed.2013.05.001","article-title":"Glutathione metabolism and Parkinson's disease","volume":"62","author":"Smeyne","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2014.05.014","article-title":"Effects of acute and sub-chronic L-dopa therapy on striatal L-dopa methylation and dopamine oxidation in an MPTP mouse model of Parkinsons disease","volume":"110","author":"Smith","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2580","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.neurobiolaging.2014.12.037","article-title":"The role of pallidal serotonergic function in Parkinson's disease dyskinesias: a positron emission tomography study","volume":"36","author":"Smith","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2585","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(90)90394-Q","article-title":"The effects of L-dopa on in vitro dopamine release from striatum","volume":"508","author":"Snyder","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2590","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1111\/j.1460-9568.2006.04758.x","article-title":"L-DOPA-induced dyskinesia in adult rats with a unilateral 6-OHDA lesion of dopamine neurons is paralleled by increased c-fos gene expression in the subthalamic nucleus","volume":"23","author":"Soghomonian","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2595","article-title":"Dopamine D3 receptor modulates l-DOPA-Induced dyskinesia by targeting D1 receptor-Mediated striatal signaling","author":"Solis","year":"2015","journal-title":"Cereb. Cortex (New York, N. Y.: 1991)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2600","first-page":"872","article-title":"5-HT2 receptor antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis","volume":"260","author":"Sorensen","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2605","doi-asserted-by":"crossref","first-page":"e13452","DOI":"10.1371\/journal.pone.0013452","article-title":"The dopamine metabolite 3-methoxytyramine is a neuromodulator","volume":"5","author":"Sotnikova","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2610","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0306-4522(84)90082-4","article-title":"Functional aspects of serotonin transmission in the basal ganglia: a review and an in vivo approach using the push-pull cannula technique","volume":"13","author":"Soubrie","year":"1984","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2615","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/syn.890010103","article-title":"Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists","volume":"1","author":"Sprouse","year":"1987","journal-title":"Synapse (New York, N.Y.)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2620","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.neuropharm.2005.09.003","article-title":"5-Hydroxytryptamine induced excitation and inhibition in the subthalamic nucleus: action at 5-HT(2C), 5-HT(4) and 5-HT(1A) receptors","volume":"49","author":"Stanford","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2625","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuropharm.2012.11.010","article-title":"L-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells","volume":"67","author":"Stansley","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2630","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1124\/jpet.114.218966","article-title":"Chronic L-dopa decreases serotonin neurons in a subregion of the dorsal raphe nucleus","volume":"351","author":"Stansley","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2635","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1007\/s00213-015-3980-4","article-title":"Behavioral impairments and serotonin reductions in rats after chronic L-dopa","volume":"232","author":"Stansley","year":"2015","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2640","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/brain\/awl346","article-title":"Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease","volume":"130","author":"Stefani","year":"2007","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2645","first-page":"157","article-title":"The nucleus raphe dorsalis of the rat and its projection upon the caudatoputamen. A combined cytoarchitectonic, immunohistochemical and retrograde transport study","volume":"77","author":"Steinbusch","year":"1981","journal-title":"J. Physiol. (Paris)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2650","series-title":"Handbook of Chemical Neuroanatomy\u2014Classical Transmitters and Transmitters Receptors in the CNS Part II","first-page":"68","article-title":"Serotonin-immunoreactive neurons and their projections in the CNS","author":"Steinbusch","year":"1984"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2655","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1471-4159.1990.tb04601.x","article-title":"Characterization of recombinant human aromatic L-amino acid decarboxylase expressed in COS cells","volume":"55","author":"Sumi","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2660","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/brain\/awu409","article-title":"Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study","volume":"138","author":"Svenningsson","year":"2015","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2665","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00213-010-1944-2","article-title":"Effect of S-COMT deficiency on behavior and extracellular brain dopamine concentrations in mice","volume":"211","author":"Tammimaki","year":"2010","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2670","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.neuropharm.2011.01.006","article-title":"Serotonin-dependent depression in Parkinson's disease: a role for the subthalamic nucleus?","volume":"61","author":"Tan","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2675","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jpsychires.2011.04.011","article-title":"High frequency stimulation of the subthalamic nucleus increases c-fos immunoreactivity in the dorsal raphe nucleus and afferent brain regions","volume":"45","author":"Tan","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2680","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.expneurol.2011.08.027","article-title":"A combined in vivo neurochemical and electrophysiological analysis of the effect of high-frequency stimulation of the subthalamic nucleus on 5-HT transmission","volume":"233","author":"Tan","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2685","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00001756-199902250-00034","article-title":"Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats","volume":"10","author":"Tanaka","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2690","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02244785","article-title":"Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?","volume":"115","author":"Tanda","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2695","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02246048","article-title":"Local 5HT3 receptors mediate fluoxetine but not desipramine-induced increase of extracellular dopamine in the prefrontal cortex","volume":"119","author":"Tanda","year":"1995","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2700","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.neuropharm.2005.12.004","article-title":"Serotonin 2A receptor antagonist treatment reduces dopamine D1 receptor-mediated rotational behavior but not L-DOPA-induced abnormal involuntary movements in the unilateral dopamine-depleted rat","volume":"50","author":"Taylor","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2705","series-title":"Biochemistry of Biogenic Amines","first-page":"327","article-title":"Brain histamine","author":"Taylor","year":"1975"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2710","doi-asserted-by":"crossref","first-page":"17087","DOI":"10.1073\/pnas.0704144104","article-title":"Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus","volume":"104","author":"Temel","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2715","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0006-8993(98)00336-9","article-title":"Dopaminergic regulation of serotonin release in the substantia nigra of the freely moving rat using microdialysis","volume":"796","author":"Thorre","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2720","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.neuroscience.2015.10.021","article-title":"The impact of combined administration of paraquat and maneb on motor and non-motor functions in the rat","volume":"311","author":"Tinakoua","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2725","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/BF00272209","article-title":"Immunohistochemistry of endogenous L-DOPA in the rat posterior hypothalamus","volume":"93","author":"Tison","year":"1990","journal-title":"Histochemistry"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2730","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02251134","article-title":"The metabolism of exogenous L-dopa in the brain: an immunohistochemical study of its conversion to dopamine in non-catecholaminergic cells of the rat brain","volume":"3","author":"Tison","year":"1991","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2735","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0304-3940(91)90422-P","article-title":"The significance of 3-O-methyldopa concentrations in the cerebrospinal fluid in the pathogenesis of wearing-off phenomenon in Parkinson's disease","volume":"132","author":"Tohgi","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2740","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0304-3940(93)90817-5","article-title":"Alterations in the concentration of serotonergic and dopaminergic substances in the cerebrospinal fluid of patients with Parkinson's disease, and their changes after L-dopa administration","volume":"159","author":"Tohgi","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2745","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1046\/j.0953-816x.2000.01370.x","article-title":"The central aromatic amino acid DOPA decarboxylase inhibitor NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats","volume":"13","author":"Treseder","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2750","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00702-002-0778-4","article-title":"Commonly used L-amino acid decarboxylase inhibitors block monoamine oxidase activity in the rat","volume":"110","author":"Treseder","year":"2003","journal-title":"J. Neural Transm. (Vienna, Austria: 1996)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2755","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nbd.2013.08.014","article-title":"5-Hydroxy-tryptophan for the treatment of L-DOPA-induced dyskinesia in the rat Parkinson's disease model","volume":"60","author":"Tronci","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2760","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bbr.2015.06.034","article-title":"Effect of selective and non-selective serotonin receptor activation on l-DOPA-induced therapeutic efficacy and dyskinesia in parkinsonian rats","volume":"292","author":"Tronci","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2765","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0361-9230(94)90092-2","article-title":"Dopamine increase in the prefrontal cortex correlates with reversal of haloperidol-induced catalepsy in rats","volume":"35","author":"Tucci","year":"1994","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2770","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0753-3322(96)82617-5","article-title":"Supersensitization of neurochemical responses by L-DOPA and dopamine receptor agonists in the striatum of experimental Parkinson's disease model rats","volume":"49","author":"Ueda","year":"1995","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2775","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0006-8993(95)00870-V","article-title":"L-DOPA inhibits spontaneous acetylcholine release from the striatum of experimental Parkinson's model rats","volume":"698","author":"Ueda","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2780","first-page":"37","article-title":"Brain neurons partly expressing dopaminergic phenotype: location, development, functional significance, and regulation","volume":"68","author":"Ugrumov","year":"2013","journal-title":"Adv. Pharmacol. (San Diego, Calif.)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2785","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0079-6123(10)84005-1","article-title":"Viral vector-mediated overexpression of alpha-synuclein as a progressive model of Parkinson's disease","volume":"184","author":"Ulusoy","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2790","doi-asserted-by":"crossref","first-page":"13159","DOI":"10.1073\/pnas.1003432107","article-title":"Presynaptic dopaminergic compartment determines the susceptibility to L-DOPA-induced dyskinesia in rats","volume":"107","author":"Ulusoy","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Supplementum","key":"10.1016\/j.pneurobio.2016.07.002_bib2795","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-201X.1971.tb10999.x","article-title":"Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour","volume":"367","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2800","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1152\/jn.00555.2013","article-title":"Abnormal functional connectivity between motor cortex and pedunculopontine nucleus following chronic dopamine depletion","volume":"111","author":"Valencia","year":"2014","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2805","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0006-8993(93)90077-Z","article-title":"Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to the rat prefrontal cortex and nucleus accumbens","volume":"624","author":"Van Bockstaele","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2810","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/0006-8993(80)90905-1","article-title":"Bilaterally situated dorsal raphe cell bodies have only unilateral forebrain projections in rat","volume":"192","author":"van der Kooy","year":"1980","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2815","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.pbb.2008.04.010","article-title":"A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model","volume":"90","author":"Vanover","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2820","doi-asserted-by":"crossref","first-page":"C104","DOI":"10.1152\/ajpcell.1998.275.1.C104","article-title":"Uptake and intracellular fate of L-DOPA in a human intestinal epithelial cell line: caco-2","volume":"275","author":"Vieira-Coelho","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2825","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.nbd.2008.11.010","article-title":"Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease","volume":"35","author":"Visanji","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2830","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/j.1471-4159.2010.07061.x","article-title":"Further evidence for an involvement of nociceptin\/orphanin FQ in the pathophysiology of Parkinson's disease: a behavioral and neurochemical study in reserpinized mice","volume":"115","author":"Volta","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2835","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S1474-4422(09)70287-X","article-title":"Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders","volume":"8","author":"Voon","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2840","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/syn.20592","article-title":"Subthalamic nucleus stimulation and lesioning have distinct state-dependent effects upon striatal dopamine metabolism","volume":"63","author":"Walker","year":"2009","journal-title":"Synapse (New York, N.Y.)"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2845","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.neuroscience.2006.12.001","article-title":"Unilateral 6-hydroxydopamine lesion of dopamine neurons and subchronic L-DOPA administration in the adult rat alters the expression of the vesicular GABA transporter in different subsets of striatal neurons and in the substantia nigra pars reticulata","volume":"145","author":"Wang","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2850","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1523\/JNEUROSCI.21-01-00035.2001","article-title":"Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition","volume":"21","author":"Wayment","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2855","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/jnr.20021","article-title":"Comparison of nerve terminal events in vivo effecting retrograde transport of vesicles containing neurotrophins or synaptic vesicle components","volume":"75","author":"Weible","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2860","first-page":"815","article-title":"Psychosis of Parkinson's disease: serotonin 2A receptor inverse agonists as potential therapeutics","volume":"4","author":"Weiner","year":"2003","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2865","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0014-2999(87)90603-0","article-title":"Dopamine re-uptake inhibitors show inconsistent effects on the in vivo release of dopamine as measured by intracerebral dialysis in the rat","volume":"135","author":"Westerink","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2870","first-page":"264","article-title":"Deep brain stimulation for movement disorders of basal ganglia origin: restoring function or functionality?","volume":"13","author":"Wichmann","year":"2016","journal-title":"Neurother. J. Am. Soc. Exp. NeuroTher."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2875","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/med.20187","article-title":"Vesicular monoamine transporters: structure-function pharmacology, and medicinal chemistry","volume":"31","author":"Wimalasena","year":"2011","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2880","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1523\/JNEUROSCI.0360-05.2005","article-title":"Pallidal origin of GABA release within the substantia nigra pars reticulata during high-frequency stimulation of the subthalamic nucleus","volume":"25","author":"Windels","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2885","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1212\/WNL.43.9.1704","article-title":"The effect of L-dopa infusions with and without phenylalanine challenges in parkinsonian patients: plasma and ventricular CSF L-dopa levels and clinical responses","volume":"43","author":"Woodward","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2890","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1152\/jn.00561.2004","article-title":"Modulation of spontaneous firing in rat subthalamic neurons by 5-HT receptor subtypes","volume":"93","author":"Xiang","year":"2005","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2895","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1124\/jpet.110.177816","article-title":"Effects of L-DOPA on nigral dopamine neurons and local field potential: comparison with apomorphine and muscimol","volume":"337","author":"Xu","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2900","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neures.2007.05.002","article-title":"Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats","volume":"59","author":"Yamada","year":"2007","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2905","doi-asserted-by":"crossref","first-page":"e0138462","DOI":"10.1371\/journal.pone.0138462","article-title":"Subthalamic nucleus deep brain stimulation modulate catecholamine levels with significant relations to clinical outcome after surgery in patients with parkinson's disease","volume":"10","author":"Yamamoto","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2910","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/00001756-200105080-00015","article-title":"Fluoxetine reduces L-DOPA-derived extracellular DA in the 6-OHDA-lesioned rat striatum","volume":"12","author":"Yamato","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2915","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1113\/jphysiol.2010.203257","article-title":"L-Dopa activates histaminergic neurons","volume":"589","author":"Yanovsky","year":"2011","journal-title":"J. Physiol."},{"issue":"11","key":"10.1016\/j.pneurobio.2016.07.002_bib2920","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1001\/jama.1970.03170110063025","article-title":"Levodopa and schizophrenia","volume":"211","author":"Yaryura-Tobias","year":"1970","journal-title":"JAMA"},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2925","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/234224a0","article-title":"Verbal communication with L-dopa treatment","volume":"234","author":"Yaryura-Tobias","year":"1971","journal-title":"Nature"},{"issue":"Suppl 2","key":"10.1016\/j.pneurobio.2016.07.002_bib2930","doi-asserted-by":"crossref","first-page":"SS123","DOI":"10.1177\/07067437720176S221","article-title":"Psychiatric manifestations of levodopa","volume":"17","author":"Yaryura-Tobias","year":"1972","journal-title":"Can. Psychiatr. Assoc. J."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2935","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.nbd.2010.08.004","article-title":"Morphological changes in serotoninergic neurites in the striatum and globus pallidus in levodopa primed MPTP treated common marmosets with dyskinesia","volume":"40","author":"Zeng","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2940","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(86)90893-0","article-title":"Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis","volume":"376","author":"Zetterstrom","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2945","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.brainres.2003.08.065","article-title":"Pharmacokinetics of L-dopa in plasma and extracellular fluid of striatum in common marmosets","volume":"993","author":"Zhang","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2950","first-page":"1181","article-title":"Decreased response of interneurons in the medial prefrontal cortex to 5-HT(1)A receptor activation in the rat 6-hydroxydopamine Parkinson model","volume":"35","author":"Zhang","year":"2014","journal-title":"Neurol. Sci. Off. J. Italian Neurol. Soc. Italian Soc. Clin. Neurophysiol."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2955","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijdevneu.2014.04.003","article-title":"Dynamic of neurochemical alterations in striatum: hippocampus and cortex after the 6-OHDA mesostriatal lesion","volume":"36","author":"Zhang","year":"2014","journal-title":"Int. J. Dev. Neurosci. Off. J. Int. Soc. Dev. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2960","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/jpet.105.094045","article-title":"Differential effects of cocaine on firing rate and pattern of dopamine neurons: role of alpha1 receptors and comparison with L-dopa and apomorphine","volume":"317","author":"Zhou","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2965","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0166-2236(90)90112-N","article-title":"Compensations after lesions of central dopaminergic neurons: some clinical and basic implications","volume":"13","author":"Zigmond","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2970","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/mds.870120105","article-title":"Levodopa induces apoptosis in cultured neuronal cells\u2013a possible accelerator of nigrostriatal degeneration in Parkinson's disease?","volume":"12","author":"Ziv","year":"1997","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.pneurobio.2016.07.002_bib2975","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1212\/WNL.45.7.1305","article-title":"Psychosis in advanced Parkinson\u2019s disease: treatment with ondansetron, a 5-HT3 receptor antagonist","volume":"45","author":"Zoldan","year":"1995","journal-title":"Neurology"}],"container-title":["Progress in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008216300351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008216300351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T22:13:01Z","timestamp":1718662381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301008216300351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":595,"alternative-id":["S0301008216300351"],"URL":"https:\/\/doi.org\/10.1016\/j.pneurobio.2016.07.002","relation":{},"ISSN":["0301-0082"],"issn-type":[{"value":"0301-0082","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expanding the repertoire of L-DOPA\u2019s actions: A comprehensive review of its functional neurochemistry","name":"articletitle","label":"Article Title"},{"value":"Progress in Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pneurobio.2016.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}